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Abstract
Posttraumatic Stress Disorder (PTSD) is a prevalent anxiety disorder that is debilitating
to both veterans and civilians following one or more traumatic events. Sleep disturbances are
hallmark features of PTSD. Sleep disturbances and PTSD remain two significant PTSD-related
issues that continue to plague veterans returning from active duty, thereby preventing full
reintegration into society. The same problem exists for civilians. This research was conducted as
a previously collected pilot study data and a secondary data analysis. The purpose of the study
consisted of: 1) examining the impact of treatment with Accelerated Resolution Therapy (ART)
on symptoms of PTSD and sleep disturbances; 2) examining the relationships and treatment
response among both subjective and objective measures of sleep function; and 3) comparing the
relationship between PTSD and sleep disturbances among military versus civilians, including the
effects of treatment with ART.
The study represents one of only a few studies consisting of subjective measures of
PTSD (PCL checklist) and sleep quality (Pittsburgh Quality Sleep Index (PSQI)), and objective
measurement of sleep function by use of electroencephalography (EEG) testing and based on a
30-minute nap protocol. The aims of this study were to: 1) investigate the effects of ART on
comorbid PTSD and sleep disturbances in U.S. veterans measured both subjectively (self-report)
and objectively (sleep EEG data) from previously collected pilot study data; 2) assess the
relationships between objective and subjective measures of sleep disturbances before and after
treatment with ART for symptoms of PTSD in U.S. veterans from previously collected pilot
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study data; and 3) compare self-report PTSD and sleep disturbances symptoms between civilians
and veterans before and after treatment with ART using a secondary analysis from two
previously conducted studies.
For Specific Aims 1 and 2, the methods consisted of previously collected pilot study
data of 8 veterans who were treated with ART at the University of South Florida, College of
Nursing. For Specific Aim 3, data were pooled from two completed studies of ART directed by
Dr. Kevin Kip that included civilians (n=75) and veterans (n=50) who were treated for PTSD.
Data analysis for Aim 1 included the use of paired t tests to compare PSQI score and each stage
of sleep measured from qEEG (Delta, Theta, Alpha, Beta, Gamma) before and after treatment
with ART. For Aim 2, Pearson correlation was used to assess the relationship between objective
measurement of sleep disturbances and subjective sleep quality before and after ART. For Aim
3, multiple linear regression models were fit with PSQI (sleep) score as the dependent variable,
PCL (PTSD) score as the primary independent variable, along with a main effect term for
military status (civilian versus military) and an interaction term (military status * PCL score).
Results for aims 1 and 2 showed the mean age of the sample to be 37.6 years, 87.5%
male, 87.5% White (non-Hispanic), 87.5% had experienced prior combat, 50% had experienced
5 or more traumatic memories that impacted their lives, and 87.5% had previous treatment for
PTSD. Sample mean scores were above established screening criteria for PTSD (PCL-M = 63.7),
sleep disturbance (PSQI = 14.5), and Center for Epidemiologic Studies Depression Scale (CESD = 28.9). For Aim 1, after treatment with ART, the mean score on the PSQI dropped 4.88
points, mean score on the PCL-M dropped -30.13 points, thereby indicating significant
reductions in sleep dysfunction and symptoms of PTSD. Mean Delta 1.5-3.5 Hz waves increased
pre/post by 299.89 (p=.032), and Theta 4-6.5 Hz waves increased pre/post mean by 83.07
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(p<0.001), both indicative of improved sleep quality. Results for Aim 2 showed statistically
significant strong inverse correlations between PSQI and Theta 1.5-3.5 Hz waves (r=-0.79) and
PSQI and Alpha 8-11 Hz waves (r=-0.89) at baseline. Post-ART, non-significant trends were
observed for higher PSQI scores and higher Beta (conscious, alert) waves. For Aim 3, mean age
of military participants (n=50) was 41.9 years versus 40.4 years among civilians (n=75, p=.439).
For the military cohort, 18% were female compared to 80% among civilians (p<0.001), with
lower Hispanic ethnicity among military compared to civilian participants (12% vs. 27%,
p=0.04). In multiple regression analysis, change in PCL score was a strong predictor of change in
PSQI score, regardless of military status PCL.
In summary, within the setting of PTSD, military participants tend to present with
different traumatic exposures and worse sleep quality compared to civilian counterparts. In spite
of these differences, the treatment protocol with ART demonstrated similar level of benefit
(reduction in symptoms of PTSD and sleep disturbance) for both military and civilian personnel.
Thus, nurses caring for individuals with PTSD, whether military or civilian, need to routinely
assess sleep disturbances and initiate an open dialogue regarding these conditions. In return,
nurses will be able to provide patients with resources to help them better understand and address
these concerns, including after experiencing restless nights of sleep. Lastly, nurses should
recognize the bi-directional temporal relationship between PTSD and sleep disturbances places.
This places a premium on assessing these conditions collectively, rather than as discrete,
independent clinical conditions.
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Chapter One:
Background
Introduction
Posttraumatic stress disorder (PTSD) is a prevalent anxiety disorder that is debilitating to
its victims following exposure to one or more traumatic events. According to the Diagnostic and
Statistical Manual of Mental Disorders DSM-V (2013), sleep disturbances and nightmares are
hallmark features of PTSD. There are four core characteristic symptoms following exposure to
traumatic incidents that include intrusion and avoidance symptoms, negative modifications in
cognitions and mood, and changes in arousal and reactivity (American-Psychiatric-Association,
2013). Comorbidity rates with respect to PTSD are often >80% and include sleep disturbances,
depression, panic disorder, substance abuse, high somatic symptom severity, decreased role
functioning, and an increased risk of suicide (Brady, Killeen, Brewerton, & Lucerini, 2000;
Kessler, 2000; Oquendo, 2003; Kessler, Berglund, Delmer, Jin, Merikangas, Walters, 2005;
Hoge, Terhakopian, Castro, & Messer, Engel, 2007; Krysinska & Lester, 2010). Of these
comorbidities, sleep disturbances is very difficult to treat, and may be refractory to treatments
that successfully resolve other PTSD symptoms (Spoormaker and Montgomery, 2008, Galovski,
et al., 2009). In terms of severity, risk of suicide is elevated in both civilians and veterans who
have experienced traumatic events such as natural disaster, violent crime, sexual assault, and
critical illness (Krakow et al, 2000; Krakow et al., 2000; Krakow et al., 2001; Krakow et al.,
2004; and Lamarche & Koninck, 2007).
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Among the civilian population in the U.S., the lifetime and past year prevalence of PTSD
have been estimated at 6.8% and 3.5%, respectively (Kessler et al., 2008). U.S. civilians
experience trauma somewhat differently than military personnel with the most common sources
of trauma being physically or sexually assaulted, being in an accident or fire, witnessing violent
death or harm to a close family member or friend including physical or sexual assault, and
witnessing a natural disaster (Kilpatrick et al., 2013). By way of comparison, the most prevalent
forms of trauma experienced among Operation Enduring Freedom/Operation Iraqi Freedom
(OEF/OIF) veterans include: 1) having a friend killed or wounded, seeing dead or seriously
injured noncombatants; 2) witnessing an accident resulting in death or serious injury, smelling
decomposing bodies; 3) having an experience with an improvised explosive device (IED); 4)
receiving an injury that does not require hospitalization, and among women, experiencing
military sexual trauma (Tanielian & Jaycox, 2008; Maguen et al., 2012).
Sleep disturbances is a broad term that can include one or more different aspects of sleep
problems including but not limited to insomnia, sleep-disordered breathing, trauma- related
nightmares, and circadian rhythm sleep disorders. Sleep disturbances encompass disorders of
initiating and maintaining sleep (insomnias), disorders of excessive somnolence, disorders of
sleep–wake schedule, and dysfunctions associated with sleep, sleep stages, or partial arousals
(Cormier, 1990). Evidence suggests that sleep disturbances appear before the onset of PTSD, and
therefore sleep disturbances could be a risk factor in development of PTSD (Koren, Arnon, Lavie
& Klein, 2002; Mellman et al., 2002; and Mellman et al., 2004). This evidence suggests that
sleep disturbances is more than a secondary symptom of PTSD -- it seems to be a core feature
(Spoormaker & Montgomery, 2008; and Lydiard & Hammer, 2009). Indeed, evidence shows that
sleep disturbances are a frequent residual symptom after successful PTSD treatment, whereas
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both sleep disturbances and severity of PTSD symptoms may be alleviated following treatments
that focus only on sleep disorders (Jacobs-Rebhun , 2000; and Zayfert & DeViva, 2004). With
respect to military PTSD, the most common types of sleep disturbances include trauma-related
nightmares in addition to insomnia and inability to maintain sleep including waking up too early,
and having non-restorative sleep.
Regarding the high prevalence of nightmares, there remains a lack of successful
interventions that target trauma-related nightmares (Cook, et al., 2010) despite evidence- based
psychotherapy for PTSD at large. This assumption comes from the notion that there is no direct
distinction between nightmares and other reoccurring phenomena (Cook, et al., 2010). Thus,
sleep disturbances and trauma-related nightmares remain two significant PTSD-related issues
that continue to plague veterans returning from active duty, thereby preventing full re-integration
into society.
Brief Historical Review of Etiology of PTSD.
In 1871, symptoms of PTSD started to be described for a certain group soldiers as
tachycardia, anxiety, breathlessness, and hyper-arousal (Javidi, & Yadollahie, 2012).
After World War I, these symptoms were given a name known as shell shock. Presently,
according to the Diagnostic and Statistical Manual V, by definition, an individual must be
exposed to trauma or a very stressful event for their diagnosis to be considered PTSD (2013).
According to Wallace, et al. (2011) recurring nightmares related to service, avoiding sleep and
frequent nocturnal checking of windows and doors within the home are all behaviors consistent
with PTSD. Hyperarousal in the presence of PTSD is when one is in a state of psychological and
physiological tension, and manifests as exaggeration of startled responses and sleep disturbances
(Krakow, et al., 2000).
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Some important traumatic events which predispose to the development of PTSD include
violent personal assault, being taken hostage or kidnapped, becoming a prisoner of war, torture,
terrorist attacks, a range of war-related and combat exposures, or severe car accidents (Russel,
2011). Of personal assaults, sexual abuse is a leading cause of PTSD in both civilians and
military personnel (Perrin et al., 2013). In addition, witnessing a crime, accident or war, as
opposed to personal involvement, is also strongly associated with development of PTSD (Perrin
et al., 2013). After a traumatic event, many individuals may develop acute symptoms (i.e. Acute
Stress Disorder) including but not limited to severe anxiety, dissociative symptoms, dissociative
amnesia, poor concentration, sleep disturbances, and de-realization (American Psychological
Association, 2013). These symptoms may resolve but, on the other hand, they can also worsen in
some individuals and progress to frank PTSD.
Comorbidity of Military PTSD and Sleep Disturbance.
Comorbidity is when two disorders occur in the same individual, simultaneously and the
interactions between the illnesses affect the course of the disease as well its prognosis (National
Institute on Drug Abuse, 2010). Recent research has reported that approximately 74% of military
personnel with sleep disturbances and PTSD symptoms rated their sleep significantly worse in
the deployed and post deployed environments, with 40% having a sleep efficiency of <85%
(Peterson, Goodie, Satterfield & Brim, 2008). Collectively, this phenomenon represents a major
health problem in terms of physical, mental and emotional functioning. Compared to the civilian
population, sleep disturbances are significantly higher among combat veterans with mood
disorders and symptoms of PTSD (Capaldi et al., 2011). Importantly, sleep disturbances have
been linked to individuals with panic disorder (PD) and alcohol dependence (AD) (Lauterbach et
al., 2011). Sleep disturbances and nightmares can be so distressing and severe that they can cause
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somatic symptoms, health dysfunction, and poor work performance (Lauterbach et al., 2011). At
times, individuals with PTSD give up, refuse, or are simply unable to sleep due the nature of
their anxiety.
Sleep disturbances impact long-term chronicity of adverse health status. Having sleep
complaints at one month can initiate post-trauma sleep conditions and significantly predict PTSD
at twelve months (Koren et al., 2002). Untreated sleep symptoms can persist for years and
intensify daytime PTSD symptoms and cause comorbid psychiatric problems and may be the
reason for the poor clinical outcomes that occur with PTSD. These conditions may contribute to
the poor clinical outcomes often observed in PTSD (Germaine et al., 2008).
Whereas sleep disturbance is commonly associated with PTSD, it is poorly understood in
terms of etiology and which treatments work best (Nakamura, Lipschitz, Landward, Kuhn &
West, 2011). First, there is considerable uncertainty as to the temporal relationship between
PTSD and sleep disturbances (i.e. the “chicken or egg” phenomena). Based on quantitative EEG
analysis, there have been discrepancies as to whether or not sleep disturbances serve as a
platform for future development of PTSD, as opposed to the more conventional hypothesis that
PTSD is a primary cause of future sleep disturbances. In reality, both directions of association
are plausible and perhaps a major reason for which there exists consistent evidence of a strong
association between PTSD and sleep quality. At the broadest level, new, evidence-based
treatments are needed that address the major clinical dilemma of comorbid military PTSD and
sleep disturbances. This challenge is the motivation for examination of Accelerated Resolution
Therapy (ART) in this setting, and the basis for this dissertation.
The Hyperarousal Symptom of PTSD.
Hyperarousal is a core symptom of PTSD (American-Psychiatric-Association, 2013) and
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often manifests as being easily startled, feeling tense or “on edge”, and having difficulty
sleeping, and/or having angry outbursts. The information from traumatic events in the setting of
PTSD is stored and processed in the brain to be adaptive (i.e. to be “on guard” for future similar
circumstances), yet is also maladaptive in everyday life. This includes, but is not limited to an
imbalance produced by insufficient control from the prefrontal cortex and parasympathetic
nervous system (physiology) over excessive amygdala and sympathetic activity (Hammer 1999,
Morris 2013, Semple 2000, Shin 2006, Zoldaz 2013).
Given this state of hyperarousal, there have been psychophysiological investigations into
triggers of symptoms of PTSD. This includes the study of increased arousal from noise and light
and physiological reactivity in persons suffering from PTSD. Increased reactivity to both traumarelated cues and unconditioned stimuli, such as loud noises, has been the topic of research for
decades. Elevated levels of physiological arousal elicited by audiovisual and imaginal reminders
of the original trauma have been reported in studies of combat veterans and traumatized civilians
of both sexes (Blanchard et al., 1986; Pitman et al., 1987; Pitman et al., 1990; Shaley et al., 1992;
Shaley et al., 1993). In addition, studies with individuals who have PTSD demonstrate greater
sympathetic responses, such as increased heart rate to strong stimuli such as loud noises (Paige et
al, 1990; Shaley et al., 1992; Shaley 1997; Orr et al., 1995; Orr et al., 1997). Recent
psychophysiological studies of PTSD have started to focus on the physiological hyperactivity of
patients to unconditioned stimuli, such as the exaggerated response toward loud noises.
Exaggerated startle response, such as to loud noises or light, is a criterion for the diagnosis of
PTSD as defined in the DSM V (American Psychiatric Association, 2013). In this realm, many
individuals with PTSD who have been exposed during combat or military training to very loud
battle noises or different assortment of lights are more likely to be startled post- deployment

6

(Shalev et al., 1998).
Conceptually, the traumatized person stays in a state of hyperarousal in an effort to
protect themselves from real life events as well as nightmares that may continuously replay in
the minds (Krakow, et al., 2000). The resultant morbidity and mortality related to lack of sleep
has been well documented and the manifestations of sleep disturbances concomitant to PTSD
include obstructive sleep apnea (OSA), periodic leg movement disorder, sleep terrors, nocturnal
anxiety attacks, and sleep avoidance (Germain, Hall, Krakow, Katherine Shear, & Buysse,
2005). Thus, with the ongoing burden and high prevalence of returning military veterans
afflicted with PTSD, addressing their sleep disturbances is critical in improving quality of life,
restoration of health, and psychological well-being (Ulmer, et al., 2011).
Current PTSD Treatment Approaches.
First-line recommended treatment approaches for adults with trauma-related issues with
PTSD vary substantially by setting (American Psychiatric Association, 2004; National Institute
for Health and Clinical Excellence, 2005; Foa, Keane & Friedman, 2008; Forbes et al., 2010;
Management of PTSD and ASR, 2010). Cognitive behavioral therapies (CBTs) are formally
endorsed and frequently used in the treatment of PTSD among veterans. This includes the use of
prolonged exposure (PE) therapy, cognitive processing therapy (CPT), and eye movement
desensitization and reprocessing (EMDR) (Resick, Schnicke, 1992; Shapiro, 2001; Friedman,
2003; Ballenger et al., 2004; Foa, Hembree & Rothbaum, 2007; Resick et al., 2012). Whereas
use of PE and CPT is promulgated as a preferred treatment modality in military and veteran
treatment settings, in civilian settings, only 17% of licensed psychologists trained in exposure
therapy reported using this modality to treat PTSD, in large part due to a reported 59% treatment
dropout rate (Becker, Zayfert & Anderson, 2004). In a similar sobering manner, a recent review
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of randomized controlled trials conducted primarily among civilians reported that approximately
two-thirds of patients who receive PE therapy or CPT (i.e. standard-of- care), retain their
diagnosis post-treatment (Steenkamp, 2015).
Accelerated Resolution Therapy (ART) is a new innovative, brief exposure-based therapy
for PTSD that has been recently studied in both civilian and military populations (Kip et al.,
2012; Kip et al., 2013). ART is delivered in just 1-5 treatment sessions over an approximate 2week timeframe. The ART protocol does not require homework or skills practice, thereby
reducing patient commitment time by more than 50% when compared to other treatments such as
PE, CPT, and EMDR. Results from empirical data from both civilians and military personnel
treated with ART were based on near-identical treatment and outcome assessment protocols
resulting in appropriate comparison of clinical presentation and treatment response (Kip et al.,
2012; Kip et al., 2013). These data provide the opportunity to examine relationships between
symptoms of PTSD and sleep disturbances, before and after treatment with ART, and among
both civilian and military adults.
Purpose of the Study.
The purpose of this study was to investigate, from a previously conducted pilot data
study, and through a separate secondary data analysis, the impact of treatment with ART on
symptoms of comorbid PTSD and sleep disturbances. This includes both subjective and
objective measures of sleep disturbances. In addition, a secondary purpose was to examine the
consistency versus discordance in sleep symptoms between civilians and veterans with PTSD,
and whether ART appears to have a differential effect on these symptoms by military versus
civilian status.
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Aims.
The Specific Aims of this dissertation were as follows:
Aim # 1: Investigate the effects of ART on comorbid PTSD and sleep disturbances in U.S
veterans measured both subjectively (self- report) and objectively (sleep EEG data), from
previously collected pilot study data.
Hypothesis # 1: ART will be effective in improving both subjective and objective measures of
sleep disturbances in U.S veterans.
Aim # 2: Assess the relationship between objective and subjective measures of sleep
disturbances before and after treatment with ART for symptoms of PTSD in U.S veterans, from
previously collected pilot study data.
Hypothesis # 2: There will be a strong association between objective and subjective measures of
sleep disturbances in U.S. veterans before treatment with ART, after treatment with PTSD, and
based on treatment-related change in PTSD symptoms.
Aim # 3: Compare self-report PTSD and sleep disturbance symptoms between civilians and
veterans before and after treatment with ART using a secondary data analysis from two
previously conducted studies.
Hypothesis # 3: Civilians and veterans will report similar self-report PTSD and sleep
disturbances symptoms before and after treatment with ART.
Significance of the Study
Since the September 11, 2001 terrorist attacks on the World Trade Center, more than 2.6
million American military personnel had been deployed to Iraq, Afghanistan, or both (U.S.
Department of Defense). Approximately 21% of the soldiers in Operation Iraqi
Freedom/Operation Endurance Freedom (OIF/OEF), after service, will receive a diagnosis of

9

PTSD (Seal et al., 2010). Approximately 70 to 90% of veterans have difficulty initiating or
maintaining sleep, and 70% of civilians who have PTSD have sleep disturbances (Mahe, Rego,
& Asnis, 2006; DaViva, Zayfert & Mellman, 2004). Evidence suggests that about 50% achieve
some level of PTSD remission yet continue to experience sleep disturbances symptoms (Zayfert,
& DeViva, 2004; Belleville, Guay, & Marchand, 2009). Among many contributing factors,
military duties and roles in both combat and noncombat environments have changed individual
sleep cycles during deployment.
In the backdrop of comorbid PTSD and sleep disturbances, current evidence-based
treatments for PTSD have highly variable results and substantial rates of drop out, and similarly,
successful interventions for major types of sleep disturbances, including target trauma-related
nightmares, remain a major challenge. Importantly, untreated sleep disturbances can persist for
decades and exaggerate daytime PTSD symptoms and associated comorbid psychiatric problems
(Germaine, et al., 2008). Thus, examination of new therapies that may effectively treat military
PTSD and sleep disturbances, in combination, is highly warranted.
Innovation of the Study.
The analyses carried out in this dissertation are innovative in several ways. First, this
study represents one of only a few studies with both subjective and objective measurement of
sleep function in veterans, and is the only study in which the influence of ART on symptoms of
sleep dysfunction by use of electroencephalography (EEG) during a 30-minute nap is examined.
Similarly, this is the only study to date in which symptoms of military PTSD and sleep
disturbances are compared between civilian and veterans, including before and after treatment
with ART. Finally, consistent with the ART protocol, this study examined whether comorbid
symptoms of PTSD and sleep disturbances in veterans can be substantially reduced with ART in
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just a few treatment sessions. This evidence would provide the rationale for larger-scale followup research, particularly given the lengthy PTSD treatment regimens currently endorsed by the
VA and DoD.
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Chapter Two:
Literature Review
Introduction
This chapter describes the conceptual framework and review of the relevant PTSD/sleep
disturbances literature. This includes review of the epidemiology and etiology of military PTSD
and sleep disturbances, risk factors for comorbid military PTSD and sleep disturbances, efficacy
of current treatment approaches, and characteristics of the ART intervention proposed in the
current study.
Conceptual Framework.
The Theory of Unpleasant Symptoms (TOUS) guides the basis for this dissertation. The
TOUS has three major components: (i) influencing factors that affect the symptom experience;
(ii) symptoms that the individual is experiencing; and (iii) consequences of the symptom
experienced (Lenz et al., 1997). Within this realm, it is not well established as to why some
individuals with traumatic experiences go on to develop PTSD, while others with similar
experiences do not. However, as reviewed briefly above, many potential factors may predispose
to the development of PTSD. Specifically, duration, intensity, quality, and timing of traumatic
exposures are risk factors for future development of PTSD (Javidi, & Yadollahie, 2012;
American Psychological Association, 2013).
Within the framework of the TOUS, a wide range of exposures and behavioral and
environmental factors can influence the development and maintenance of PTSD (Figure 1). Once
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present, PTSD is often associated with comorbidities including but not limited to symptoms of
anxiety, depression, and substance abuse and dependence. With respect to military PTSD, the
strength and consistency of potential risk factors varies considerably. Figure 1 depicts the “full”
conceptual framework for the TOUS with respect to development of comorbid PTSD and sleep
dysfunction. This “full” model is based on a review of the literature and includes the three major
etiological components of: (1) Influencing Factors à (2) Symptom Experience à (3) Symptom
Consequences. As depicted in the figure, there exist a large number of predisposing and military
service factors that may contribute to the development of PTSD.

Figure 1. Full Conceptual Framework
For the purpose of this dissertation, a “pared down” model of the TOUS was used.
Specifically, as seen in Figure 2, this dissertation is limited to the two major etiological
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components of: (1) Influencing Factors and (2) Symptom Experience, and also a reduced set of
risk factors for PTSD. This approach is consistent with the three specific aims of this research,
and also was selected based on the specific data variables available in the pilot study (specific
aims 1 and 2) and secondary data analysis (specific aim 3).
With this approach, the risk factors for PTSD reviewed below include: (i) predisposing: prior
psychiatric history; (ii) military service: length of deployment and multiple deployments,
exposure to combat, military sexual trauma, sleep disturbance; and (iii) post-deployment: sleep
disturbances.

Figure 2. Pared Down Conceptual Model
Theory of Unpleasant Symptoms Component #1. Influencing Factors:
Predisposing Risk Factor for Development of PTSD.
Psychiatric History and Risk of Suicide. Prior psychiatric history can lead to increased
risk of PTSD. The U.S. Army suicide rate doubled between the years of 2004–2005 and 2008–
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2009 and reached an all-time high of 27.9/100,000 in 2012 (Schoenbaum M, Kessler RC, Gilman
SE, et al, 2014). Given the demand and strong need, the Army created suicide prevention
programs. Many of the responses from participants with mental disorders made a connection of
suicide, and the prolonged military operations in Iraq and Afghanistan were the leading causes of
high rates of mental health cases among these veterans. Evidence also showed that many soldiers
are not seeking treatment for the mental issues due to stigmatization (Hoge CW, Castro CA,
Messer SC, McGurk D, Cotting DI, Koffman RL, 2004; Held P, Owens GP, 2013; & Kim PY,
Britt TW, Klocko RP, Riviere LA, Adler AB, 2011).
To address the major challenge of mental illness among veterans, beginning in 2006, the
Department of Defense (DoD) authorized post-deployment screening in order to identify soldiers
returning from deployment with behavioral health problems (Zinzow HM, Britt TW, Pury CL,
Raymond MA, McFadden AC,Warner CH, Breitbach JE, Appenzeller GN, Yates V, Grieger T,
Webster, 2007). However, with the more recent movement of identifying these veterans, the
stigmatization and underreporting has decreased validation of studies in post-deployment
screening. Moreover, the limited focus of these surveys has made it very difficult to estimate the
actual extent and correlation of untreated mental disorders and causes (Hourani L, Bender R,
Weimer B, Larson G, 2012). Jeon et al. (2014) conducted a study where lifetime suicide attempts
(LSA) were significantly more frequent in persons with major depressive disorder (MDD) and
who had experienced six types of traumas including military combat, witnessing a violent crime,
rape or sexual assault, being badly beaten, being threatened by others, and learning of trauma
experienced by others.
Capone (2013) conducted a study regarding other Axis I disorders. A total of 25
participants met criteria for current Major Depressive Disorder (MDD). Rates of other current
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Axis I disorders in the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) in this
sample were relatively low. Four participants had diagnoses of Generalized Anxiety Disorder
(GAD) and two had diagnoses of panic disorder. Nine participants endorsed symptoms consistent
with current alcohol abuse, and an additional nine participants met criteria for current alcohol
dependence. The authors stated being interested in history of Alcohol Use Disorder (AUD), since
prior drinking and related impairment may be relevant to current relations between PTSD and
alcohol use. As far as a lifetime AUD, 52 participants met criteria for alcohol abuse and 50 met
criteria for alcohol dependence at some point during their lifetime.
Military Service Risk Factors for Development of PTSD. Military personnel often
have risk factors for the development of PTSD. Elbogen et al. (2014) conducted a risk factor
study and found significant relationships (p<0.05) between financial instability, combat
experience, alcohol misuse, violence or arrests anger, violence and developing PTSD. Phillips,
Leardmann, Gumbs & Smith (2010) conducted a study on predisposing risk factors and
discovered adverse childhood experiences, prior violence exposures, pay grade, number of
deployments, number of close friends or relatives at follow-up, and race/ethnicity were
significantly associated with PTSD. O'Toole, Marshall, Schureck & Dobson (1998) conducted a
study about risk factors for military personnel where there was a significant finding that men
with PTSD reported a greater incidence of assault or mugging. They were also more likely to
have admitted to a pre-enlistment civilian criminal record; these were usually juvenile offences,
as major crimes would have prohibited enlistment.
Length of Deployment and Multiple Deployments. The length of time and multiple
deployments can play a role in the health of a soldier. Fear et al. (2010) conducted a study about
the effects of multiple deployments in which overall, 4.0% of participants reported probable
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PTSD, 19.7% reported a common mental disorder, and 13.0% reported alcohol misuse.
MacGregor, Han, Dougherty & Galarneau (2012) conducted a study that found that overall, 80%
of those with two deployments were home for at least as long as the length of their first
deployment. The rate of PTSD overall and other mental health disorders was 1.5% and 6.1%,
respectively, with higher rates of PTSD among military personnel with two deployments
compared to those with a single deployment (2.1% versus 1.2%) and, conversely, higher rates of
other mental health disorders among those with a single deployment compared with two (6.3%
versus 5.7%). A breakdown of the other mental health disorder category indicates substance
abuse disorder as the most common subcategory, with higher rates among those with one
deployment than among those with two (2.4% versus 1.7%). Similarly, mood disorders were
slightly higher among those with a single deployment.
Exposure to Combat. There are several reactions soldiers can have from combat. Tracie
Shea, Reddy, Tyrka & Sevin (2013) conducted a study that showed those with PTSD
significantly differed from those without PTSD on multiple hypothesized risk variables with the
exception of perceived preparation and training and unit support. Data on combat experiences
were available for 219 participants. Of these, 59% reported receiving small arms fire, 57%
having seen dead bodies, 56% with exposure to Intermittent Explosive Device explosions, 55%
attacked or ambushed, 54% knowing someone injured or killed, 37% seeing dead or injured
Americans, 33% clearing homes or buildings, 30% one or more casualties within their unit, 20%
handling dead bodies, 15% being injured, 11% being responsible for the death of the enemy, and
1% being responsible for the death of a noncombatant (Tracie Shea, Reddy, Tyrka & Sevin,
2013).
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Military Sexual Trauma. Military sexual trauma is most common among women in the
military. It is also beginning to be more common in men in today’s society. Decker,
Rosenheck,Tsai, Hoff & Harpaz-Rotem (2013) conducted a study on participants who reported
military sexual trauma (MST) and were more likely to be currently married and to endorse
greater severity of PTSD and psychiatric symptoms. Homeless female veterans who reported or
experienced MST significantly endorsed lower self-esteem, quality of life, and did not feel safe
in their neighborhoods, and as victims in the past year. Kimerling (2007) conducted a study that
reported the association of PTSD with MST to be almost three times stronger among women
than among men. The link between MST and adjustment disorders was significantly stronger
among men than among women. Alcohol disorders and anxiety disorders were more common
among both men and women who reported MST, but the relation to MST was significantly
stronger among women than among men. The relation of MST to bipolar disorders and
schizophrenia or psychoses was strong among men and women, but significantly stronger among
men. Women were more likely to show signs of dissociative, eating, and depressive disorders
than men.
Post-Deployment Risk Factors for Development of PTSD.
Sleep Disturbance. Sleep disturbances have played a central role in predicting
development of PTSD after exposure to trauma (Schoenfeld, 2012, Harvey & Bryant, 1998;
Mellman, David, Bustamante, Torres, & Fins, 2001; Koren, Arnon, Lavie, & Klein, 2002), and
have been a hallmark symptom of PTSD. Studies have found that sleep disturbance, such as
nightmares, are more prevalent in victims who experienced trauma and developed PTSD before
the trauma occurred (Mellman et al., 1995; Van Liempt, 2012). Sleep disturbances can also be
residual symptoms after PTSD treatment (Zayfert & DeViva, 2004). Furthermore, having
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persistence of sleep disturbances after PTSD treatment can be a negative sign for long-term
consequence in various psychopathological and somatic domains of the body (Belleville, Guay,
& Marchand, 2011). Sleep disturbances and difficulties due to intrusive thoughts or bad dreams
about a certain event seem to have a strong relationship with reactivating symptoms of PTSD
(Boe et al., 2010).
Recurring military-related nightmares, such as avoiding sleep because of nocturnal
checking ‘safety perimeter’ behaviors or frequent checking of windows and doors in the home
environment, are all-incongruent with sleep initiation. Abnormalities in rapid eye movement
(REM) support findings of centrally measured hyperarousal during sleep in PTSD (Mellman,
1995). Some researchers have found co-morbid mild sleep-disordered breathing (SDB) to be
common in patients with PTSD while others have not (Breslau et al., 2004; Krawkow et al.,
2004). Actigraphic data in PTSD is not common, but a few studies have used this method to
estimate total sleep time (TST) and awakenings in veterans with PTSD (Westmeyer et al.,
2007). Most studies of returning Operation Enduring Freedom/Operation Iraqi Freedom
(OEF/OIF) veterans and civilians’ sleep quality have relied on subjective responses to a
single-item sleep embedded instrument that have not focused on validated sleep questionnaires
from the objective aspect in home environments (Lundin, de Boussard,, Edman, & Borg,,
2006; Seelig, 2006; Lew et al, 2007; Lew et al., 2010; McLay, Klam & Volkert, 2010).
Insomnia in particular appears to be associated with both severity and chronicity of
PTSD. Pigeon, Campbell, Possemato, and Ouimette (2013) reported insomnia being associated
with significantly higher severity of PTSD and depression at the six-month assessment.
Contingency table analyses comparing baseline insomnia status to rates of diagnostic level PTSD
six months later revealed that 20 of 53 participants with insomnia (37.7%) had PTSD at six
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months compared to only 1 of 19 (5.3%) of those without insomnia (df = 1; X2 = 7.14; p < .01)
(Pigeon, Campbell, Possemato, and Ouimette, 2013). Again, these data reinforce the need for
better understanding of the relationships between PTSD and sleep disturbances.
Theory of Unpleasant Symptoms TOUS Component #2. Symptom Experience:
Insomnia. Insomnia is a major symptom experience of PTSD with inadequate treatment
options today. Although veterans with PTSD seem to experience poor sleep overall, there is not
unexpectedly night-to-night variability in the severity, as has been documented in individuals
with primary insomnia (Perlis et al., 2010). One potential source of this variability is the
participants’ daytime experiences. Self-reported stress levels are known to correlate with sleep
disturbances across individuals (Healey et al., 1981). It is reasonable to suspect that, within an
individual, days with higher levels of stress may be followed by worse sleep and more
nightmares the following night. According to Gehrman et al. (2014), greater pre-treatment PTSD
severity, as assessed by the PCL-M, is associated with more awakenings, shorter sleep time,
longer sleep latency, and more nightmares over the six weeks of diary completion. In terms of
potential treatment options, there are some encouraging indications.
Abramowitz, et al. (2008) conducted a randomized controlled study to compare the
efficacy of symptom-oriented hypnotherapy (n=17) versus pharmacotherapy with 10mg
zolpidem (n=16) among chronic combat-related PTSD patients with insomnia. All participants
were assessed for PTSD and sleep disturbances symptoms. There was a significant main effect in
the treatment group, F (1, 30)=4.96; p=0.034, with PTSD symptoms as measured by the
Posttraumatic Disorder Scale (PDS) being lower in the hypnotherapy group (HT) compared to
the zolpidem group (ZT). Cognitive behavioral therapy for insomnia (CBT-I) has been shown to
improve sleep in individuals with PTSD, with durable gains at 6 month (Roszell, McFall, Malas,
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1991). In addition, overall psychosocial functioning improved following CBT-I. The initial
evidence regarding CBT-I and nightmares is promising, but further research (i.e. the present
proposed use of ART) is needed (Talbot, et al. 2014).
Nightmares. Nightmares are also highly prevalent symptoms in the setting of PTSD. Up
to 90% of individuals with PTSD report nightmares and insomnia (Roszell, McFall, Malas 1991;
Ohayon & Shapiro, 2000). Participants with nightmares, compared to those without significant
nightmares, also had higher baseline levels of PTSD severity as measured by the PCL checklist
(Pigeon, W.R, Campbell, C.E., Possemato, K., and Ouimette, P, 2013). Regarding potential
treatment options for nightmares, Rhudy, et al. (2010) conducted a randomized control study
(n=30) to assess the impact of Exposure, Relaxation, & Rescripting Therapy (ERRT) on
physiological and subjective measures of negative affect and fear in response to personal,
nightmare-related imagery. ERRT is a brief, 3-session treatment that directly targets nightmares
in trauma-exposed persons. It was predicted that ERRT would decrease physiological and
subjective reactivity to nightmare imagery. Physiological reactions to nightmare imagery were
lower at post treatment than baseline for the treatment group (p< 0.01), whereas physiological
reactions of the control group did not change over time (p > 0.40). Limitations include the
relatively small sample size, the fact that procedures did not control for physiological-emotional
reactivity due to the personal relevance of the nightmare script, and no objective measurements
of sleep disturbances.
Germaine, et al. (2007) piloted a single, behavioral intervention session that combined
image rehearsal therapy (IRT), stimulus control, and sleep restriction in a sample (n=7) of adult
victims of violent crimes with PTSD. Participants received a single, 90-minute intervention
session and were instructed to change a nightmare they experienced in any way they wanted, and
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to rehearse one or two new dream scenarios during the day, at least three times per day for a
minimum duration of 5 minutes. Overall, participants showed small-to-moderate improvements
in self-report sleep quality and sleep disturbances. Self-reported dream frequency was markedly
decreased post-intervention. Improvements in sleep were accompanied by marked improvements
in overall daytime PTSD symptom severity and individual PTSD symptom clusters. This
included improvement on the Pittsburgh Sleep Quality Index (PSQI) and nighttime PTSD
symptoms (p < 0.1) and daytime PTSD, intrusion, and hyperarousal symptoms (p < .05).
Findings from this study are limited due to small sample size and reliance on self-report
measurement of sleep disturbances.
Fragmentation and Awakenings. Individuals with PTSD report specific types of sleep
disturbances including fragmented sleep and multiple awakenings. A recurrent nightmare among
individuals with PTSD is a principal source of awakenings and among the most common and
distressing symptoms. Historically, most sleep studies among PTSD subjects have been based
upon subjective reports. However, some studies have objectively tested sleep quality and REM
fragmentation by use of polysomnography (e.g. Mellman, et al., 2007). Sleep has a restorative
function and affects emotional regulation whereas poor sleep adversely affects emotional
processing of traumatic experiences (Maher, et al., 2006). Future research using objective
measurements of sleep quality, including fragmentation and awakenings, is needed for proposed
treatment options.
Non-restorative Sleep.
With sleep’s restorative nature, it affects emotion regulation and poor sleep may affect
the emotional processing of traumatic experiences for individuals (Horne, 1993; Walker, 2009,
Maher et al., 2006). When compared to control subjects, studies using objective sleep measures
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have suggested that patients with PTSD have: (1) greater REM density (frequency of rapid eye
movements that is characteristic of a dream state); (2) hyperarousal and nonrestorative sleep with
frequent brief awakenings of less than one minute across all sleep stages; (3) a greater number of
shifts from REM to lighter sleep per hour of sleep; and (4) decreased stage 4 (slow wave) sleep,
the most restorative sleep stage (Neylan, et al., 2003, Breslau, et al., 2004). Importantly, the
REM state is the only time during sleep when the chemistry of the brain is changing. Somewhat
paradoxically, Khawaja et al. (2013) reported that shorter sleep time was associated with more
awakenings among veterans with a lifetime history of PTSD, and not surprisingly, such impaired
sleep was linked to not awakening refreshed from sleep in the morning and daytime sleepiness.
In terms of treatment, quality of sleep (i.e. restorative sleep) has been shown to be higher
in a hypnotherapy (HT) group compared to a group treated with zolpidem (ZT)(p=0.003), and
was improved from the first to the second assessment (p <0 .0005) (Krakow et al, 2000). In this
trial, findings are limited because the hypnotherapeutic intervention was added to ongoing
treatment and thus its sole contribution is difficult to tease out. In addition, only self-report sleep
disturbances data were collected.
Comorbidities. There is much comorbidity that may result as a symptom experience to
PTSD. Kimbrel et al. (2014) examined the relationship between clinician-based PTSD diagnoses
and screening positive on non-PTSD Psychiatric Diagnostic Screening Questionnaire (PDSQ)
subscales. As a result, veterans who met criteria for PTSD were significantly more likely to
screen positive for depression, χ2=28.010(1), p<0.001, panic disorder, χ2=38.065(1), p<0.001,
social phobia, χ2=19.636(1), p<0.001, and generalized anxiety disorder, χ2=23.303(1),
p<0.001(Kimbrel et al., 2014). There was an absence of a relationship between substance use and
trauma. Irwin et al., 2014 conducted a study on relationship and impact of depression and anxiety
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on PTSD. The results of this study support the theory that anxiety and depression symptoms may
mediate the relationship between PTSD symptoms.
Emergence of Accelerated Resolution Therapy (ART). The emergence of
Accelerated Resolution Therapy (ART) is based in large part on the limitations of current
evidence-based therapies endorsed for treatment of military PTSD. In brief, evidence-based
cognitive-behavioral therapy (CBT) has been recognized as the first-line treatment for PTSD
by both the Veterans Administration and the Department of Defense. Presently, the most
commonly used and practiced therapies for the treatment of PTSD for veterans are Prolonged
Exposure (PE) therapy, Cognitive Processing Therapy (CPT) and Eye Movement
Desensitization and Reprocessing (EMDR) (Resick, Schinicke, 1992; Ballenger et al., 2004;
Nemorff, 2006; Foa, Hembree & Rothbaum, 2007; Resick et al., 2012).
Prolonged exposure therapy involves 10-12 sessions approximately 90 minutes each with
corresponding homework assignments (Foa, Hembree & Rothbaum, 2007). The homework
requirement is quite demanding. There are two assignments every day that require 1.5 to 2 hours
to complete (Resick et al., 2007). This totals approximately 30 to 35 hours of dedicated treatment
time over two weeks. In addition, treatment is far from absolute with dropout rates of 50% in
some clinical trials of PE and non-response rates between 20-67% (Minners & Hagenaars, 2002;
Hembree et al. 2003; Schurr et al., 2007; Schottenbaurer et al., 2008). Cognitive processing
therapy (CPT) for treatment of PTSD consists of 12 sessions lasting 60-90 minutes with practice
of learned skills outside of the therapy skills (Resick and Schnicke, 1996). The dropout rates for
this therapy are approximately 4-29% with non-response rates between 4-48% (Hembree et al.,
2003; Schottenbauer et al., 2008. Eye Movement Desensitization Reprocessing (EMDR) consists
of 8-12 weekly 90-minute sessions with dropout rates up to 36% and non- response rates
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between 7 and 92% (Friedman, 2003; Schottenbauer et al., 2008). Thus, despite these therapies
being universally endorsed as first-line treatment for PTSD, they all portend significant
limitations including variable efficacy, frequent dropout rates, and lengthy treatment regimens
(Kip et al., 2013).
In response to limitations of the current endorsed treatments for military PTSD, ART
is an emerging brief exposure-based psychotherapy that was developed in 2008. The ART
protocol uses the evidence-based components of imaginal exposure, imagery rescripting, and
smooth pursuit eye movements. ART addresses the sentinel PTSD features of distressing
emotions, thoughts, sensations, and images in particular, by viewing the development and
maintenance of PTSD symptoms as a consequence of a failure of a traumatized individual to
exhibit extinction of the affective component of the memory. To date, two empirical studies of
ART have been completed, including a prospective cohort study in civilians and a randomized
controlled trial conducted among 57 service members and veterans. Kip et al (2013) reported
in their randomized trial the mean pre-/post-change on the PCL-M was -17.2 ± 13.4 in the
ART group versus -2.5 ± 6.0 in an Attention Control (AC) group (effect size = 1.39; p <
0.0001). These completed studies have resulted in multiple peer-reviewed publications.
For both completed studies of ART, strong, beneficial clinical effects were reported
for treatment of symptoms of PTSD in both civilians in veterans. With respect to
comorbidities of PTSD, strong effects were reported for concomitant reductions in symptoms
of depression and anxiety, and to a lesser extent, reductions in substance abuse and aggression
and higher levels of self-compassion. Of note, improvements in self- reported sleep
disturbances were also reported with ART, and serve as the basis for more detailed
examination of these effects in Aim #3 of this proposal.
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Sleep Disturbance. As a risk factor for the development of PTSD during military service
and sustainment of PTSD post-deployment, the relationship between PTSD and sleep
disturbances was previously reviewed above.
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Chapter Three:
Methods
Introduction
This chapter outlines the research methods and procedures used for this study. The
first section discusses the research design; this is followed by the setting and sample,
instrumentation procedures, and data analysis procedures. The chapter is divided in 2
sections. The first section pertains to Specific Aims 1 and 2 and the examination of the
pilot study data of ART and subjective and objective measures of sleep disturbances. The
second section pertains to Specific Aim 3 and the secondary data analysis of two
previously completed studies of ART.
Research Design.
The previously conducted pilot study data, which corresponds to specific aims 1
and 2, is a prospective cohort study design that made use of self-report and objective (sleep
EEG) pre- and post-measurements of symptoms of PTSD and sleep disturbances before
and after treatment with ART. The secondary data analysis, which corresponds to specific
aim #3, merged “civilian” and “military data from two completed federally funded studies
of ART for treatment of psychological trauma. The original “civilian” study made use of an
uncontrolled prospective cohort design. The “military study was a randomized controlled
trial of ART versus an attention control regimen. All subjects in the attention control
regimen were offered ART after 2 sessions of the control condition, and >90% ultimately
received ART. Therefore, for this purpose of this analysis, the data from the military
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randomized controlled trial are treated as prospective cohort data with treatment response
assessed within subjects both before and after treatment with ART.
Specific Aims # 1 and # 2.
Population.
Setting and Sample. This pilot study was originally designed to enroll a total of 10
subjects and ultimately enrolled 8 subjects (veterans). For purposes of analysis, eligibility
required participants to have evidence of PTSD and at least a modest level of sleep
disturbances. The inclusion criteria were: (1) at least 18 years of age; (2) a U.S. service
member or veteran; (3) ability to read and speak English to complete survey questions; (4)
denial of suicidal and homicidal ideation or intent, and no evidence of psychotic behavior
or being in psychological crisis (determined by the medical form and discretion of the
clinician and Psychiatric Diagnostic Screening Questionnaire (PDSQ); and (5) symptoms
indicative of comorbid psychological trauma and sleep dysfunction (determined from the
17-item PCL-M (PTSD checklist) and the Pittsburgh Sleep Quality Index (PSQI)).
For PTSD symptoms, a score of >44 on the 17-item PCL-M were used to define
significant symptoms of PTSD (Blanchard, 1996). For sleep dysfunction, a score of >5 on
the Pittsburgh Sleep Quality Index (PSQI) (sleep quality screening tool) were used to
define significant symptoms of sleep disturbances (Buysse, Reynolds, Monk, Berman, &
Kupfer, 1989). Exclusion criteria were: (1) brain injury prohibiting speech, writing, and
purposeful actions; (2) major psychiatric disorder (e.g. bipolar disorder) concomitant to
symptoms of psychological trauma (determined by the medical form and Psychiatric
Diagnostic Screening Questionnaire (PDSQ; (3) currently undergoing substance abuse
treatment (e.g. alcohol, opioid, cocaine) (determined by the PDSQ); and (4) any medical
condition that, in the judgment of the Principal Investigator and/or ART therapist, may
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place the individual at high risk due to a potential heightened emotional reaction (e.g.
previous heart attack, seizure disorder).
Sample Size and Power Analysis. The original proposed sample size of 10
subjects was designed to provide 80% power to detect a “large” within-subject effect size
(assuming type I error rate of 0.05) of 0.84. To evaluate the relationship between subjective
and objective measures of sleep disturbances (assessed at 3 intervals), and using the same
assumptions (i.e. desired sample size of 10 subjects) and within-subject correlation of 0.50,
a “medium” non-zero order correlation of 0.48 would be detectable at 80% power. Given
these power calculations, it should be recognized that the design was clearly intended to be
exploratory and of a pilot nature. Similarly, the pilot study was deemed to be of insufficient
size to control for covariates in the analysis and as part of power calculations.
Instrumentation. The instruments described below were used to measure response
before and after treatment with ART. Of note, with the exception of the objective
measurement of sleep response (described below), the same self-report instruments were
used for the secondary data analysis (specific aim #3).
PTSD Response (DSM-IV)
PTSD Checklist (PCL) – This is a 17-item self-report measure of the 17 DSM-IV
symptoms of PTSD. Respondents rate how much they were “bothered by that problem in
the past month.” Items are rated on a 5-point scale ranging from 1 (“not at all”) to 5
(“extremely”). The PCL can be scored in multiple ways. A total score (range 17-85) can be
obtained by summing the scores from each of the 17 items. Cutoff scores for a probable
PTSD diagnosis have been validated for some populations, but may not generalize to other
populations. Another way to score the PCL is to follow the DSM-IV criteria. It has been
suggested that a combination of these two approaches (i.e., the requisite number of
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symptoms are endorsed within each cluster AND the total score is above the specified cut
point for a specific population) may be best. Cronbach’s α reliability has been reported as
0.97 (Blanchard, 1996; King et al., 2013).
Sleep Response – Self Report
Pittsburgh Sleep Quality Index (PSQI): This 15-item self-report developed in
1989 (Buysse et al., 1989) measures the quality and patterns of sleep in adults. It takes
approximately 3 to 6 minutes to complete. A global PSQI score greater than five has
yielded a diagnostic sensitivity of 89.6% and specificity of 86.5% (kappa = 0.75, p < 0.001)
in distinguishing good and poor sleepers. Thus, a score of >5 indicates a positive screening
for sleep disturbance. The internal consistency reliability coefficient (Cronbach’s alpha) for
the PSQI has been reported as 0.88 (Farrahi, Nakhaee, Sheibani, Garrusi, & Amirkafi,
2009).
The PSQI-Addendum (PSQI-A): is used to identify disruptive nocturnal
behaviors that are characteristic of PTSD among military personnel (Germain et al., 2005).
The PSQI-A is comprised of seven different sleep disturbance items such as memories or
nightmares of the traumatic experience, and episodes of terror during sleep. Items are rated
on a 0 to 3 point scale, where 0 means not in the past month and 3 means three or more
times a week. They are summed to create a total score. Thus, the total score can range from
0 (normal) to 21 (severe). Internal consistency is reported as high, with a Cronbach’s alpha
of 0.89 (Germaine et al., 2005).
Intake Forms:
Medical History Form: This form provides current and past medical history. This includes
whether the participant has been previously been treated for PTSD or any other mental
condition, as well as current use of medications.
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Demographics Form: This form asks the participant about background information
including age, gender, ethnicity, marital status, employment status, years of education,
military status, branch of the military served in, number of overseas tours served in the
military, and deployment and combat experiences.
ART Intake Assessment Form: This form is used by the clinician form to determine an
appropriate treatment approach to be used with ART. It specifically asks the number of
traumatic memories that are currently impacting one’s life, and the specific traumas that the
veteran seeks to resolve through treatment with ART. It also inquires about having a
current disability for PTSD or another mental health condition, as well as the length of time
that the veteran has lived with one or more traumas.
Sleep Response – Objective Measurement (qEEG)
Use of quantitative electroencephalography (qEEG) has a long history in medical research.
In brief, the method is used to obtain basic brain patterns of individuals while in a relaxed
state (Teplan, 2002). For the pilot study, qEEG measures were collected on each veteran by
use of acquisition of multi-channel surface EEG during a daytime nap, with duration of 30
minutes (generic example in Figure 3).

Figure 3. EEG
This occurred before treatment with ART and after completion of treatment with
ART. Surface EEG electrodes were attached to the frontal sites: F3 F4, central sites: C3,
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C4, and parietal sites: P3, P4 of the two hemispheres according to the International10-20
EEG placement sites (Jasper, 1958). Measurement of the following EEG frequency bands
was performed: Delta (δ): 1-3.5 Hz; Theta (θ): 4-7.5 Hz; Alpha (α): 8-12 Hz; Sigma (σ):
13-16 Hz; Beta (β): 16.5-25 Hz; and Gamma (γ): > 30 Hz. For analytical purposes, values
were expressed as non-normalized (raw) and normalized by use of a square root
transformation. The analyses were based on 5-minutes of data recording following the start
of transition to a sleep state.
Comorbidity Measurement
Centers for Epidemiological Studies Depression Scale (CES-D): The CES-D is a
widely used 20-item self-report scale which measures the current level of depressive
symptomatology in the general population, with an emphasis on depressed mood during the
past week. The scale measures frequency of depressive feelings and behaviors on a fourpoint scale (‘rarely or none of the time,’ to ‘most or all of the time’). The possible range is
0-60 with a score of 16 as being indicative of a positive screening of depression. The CESD incorporates the main symptoms of depression and was derived from five validated
depression scales, including the Beck Depression Inventory (BDI). Internal consistency has
been reported as relatively high, with a Cronbach’s alpha of 0.79 (Radloff, 1977).
State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA)- The 21item self- administered questionnaire in the general population, the State-Trait Inventory
for Cognitive and Somatic Anxiety (STICSA) was designed to assess cognitive and
somatic symptoms of anxiety as they pertain to one's mood in the moment (state) and in
general (trait). There are a total of 20 questions with a four-point summated scale ranging
from 1 with no anxiety to 4 with extreme anxiety. The cutoff point of being positive for
screening of this questionnaire is a score of 39. The instrument items take an estimated 6
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minutes to complete. The STICSA is a reliable and valid measure of state and trait
cognitive and somatic anxiety, with coefficients ranging from 0.91 (Kim et al., 2008).
Psychiatric Diagnostic Screening Questionnaire (PDSQ): The PDSQ is a 125item (yes/no) instrument used to screen for Axis I disorders in the general population and
serve as a global assessment of psychopathology. It can be quickly hand scored to obtain a
total score plus scale scores for 13 disorders: Major Depressive Disorder, Generalized
Anxiety Disorder, Panic Disorder, PTSD, Alcohol Abuse/Dependence, Drug
Abuse/Dependence, Psychosis, Bulimia/Binge-Eating Disorder, Obsessive-Compulsive
Disorder, Somatization Disorder, Social Phobia, Agoraphobia, and Hypochondriasis. Six
items on the depression scale provide a measure of suicidal ideation. Internal consistency
(Cronbach's alpha coefficient) for the PDSQ has been reported as 0.82 (Zimmerman &
Mattia, 1999).
Procedures
Approval. The Institutional Review Board at the University of South Florida
previously granted approval for this study (Pro 00011530).
Recruitment Procedures.
Veterans were recruited from multiple sources including community-based
organizations and veteran membership organizations within the greater Tampa Bay area, as
well as academic programs at USF. Recruitment through the USF Office of Veterans
Services was based on the established relationships between Dr. Kip and his research team
and retired Lieutenant Colonel Larry Braue, Ed.D., Director of Veteran Services at USF. A
recruitment flyer was developed for the study and distributed at community- based events,
including local presentations (e.g. Rotary Club) on ART made by Dr. Kip, PI of the parent
study.
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Upon initial contact, the research coordinator presented the consent form to
potential participants based on their inquiry about the study. Potential participants were
encouraged to take their time in reviewing the consent form and to discuss study
participation with a friend or family member. Veterans who consented to participate signed
the informed consent form and were provided a copy for their records. The Informed
Consent form stated that partaking in the study would not affect the participant’s military
benefits including payments, disability status, or diagnosis. Patient confidentiality and
security and of all study data was maintained by having password protected computers and
locking up all case report forms in Dr. Kip’s office.
Data Collection.
Clinical evaluations used for screening and trial eligibility consisted of multiple preART screening instruments including the PCL-M Checklist, Pittsburg Sleep Quality Index
(PSQI), Psychiatric Diagnostic Screening Questionnaire (PDSQ), and Accelerated
Resolution Therapy (ART) Standard Protocol questionnaire. In addition, participants
completed a demographic data form and clinical history on medical and mental health
history. The ART Clinical Director, Dr. Hernandez, who conducted the initial intake
evaluation with study participants, confirmed their eligibility for the study by reviewing the
data.
Description of ART Intervention.
Description of the ART protocol has been published. (Kip et al 2012, Kip et al
2013, Kip et al 2014). In brief, the ART protocol was delivered using the four core
elements found in most A-level trauma-focused psychotherapies (U.S. Department of
Veterans Affairs 2015). In the first major component of ART, imaginal exposure was used
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whereby veterans were asked to recall (verbally or non-verbally) details of the traumatic
event while focusing their attention on physiological sensations, thoughts, and emotions.
With coaching from the ART clinician, the veteran was composed into a relaxed and alert
state of mind, and is then exposed to re-activation of the targeted memory for a very short
period of time (30-45 seconds). This short period of exposure to the memory was
immediately followed by identification and diminishment (or eradication) of the emergence
of any uncomfortable emotional or somatic symptoms. Two complete phases of
intermittent exposure to the targeted memory were performed.
In the second major component of ART, imagery rescripting was used whereby the
veteran imagined a new way to think about the trauma in order to change (replace) the
negative traumatic narrative, including sensory material and images, to positive material.
This approach is consistent with memory reconsolidation and the work of Smucker who
noted that much of the cognitive-affective disturbance associated with intrusive traumarelated memories is embedded in the traumatic images themselves, and that modifying the
traumatic imagery becomes a powerful, if not preferred, means of processing the traumatic
material (Smucker 1997).
During both imaginal exposure and imagery rescripting, the veteran followed the
therapist’s hand back and forth moving their eyes from right to left, with 40 bilateral eye
movements performed per set. During both components, the veteran was not speaking, but
rather “watching” his or her original or newly imagined scene. Treatment of the scene was
considered complete (successful) when an acceptable alternative was imagined to
satisfaction, and the physiological and emotional intensity of the memory was altered and
minimized. By protocol, the number of planned treatment sessions ranged from 1 to 5
based on the extent of prior trauma history. The individual treatment sessions were
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scheduled for approximately one hour with additional time allocated as needed.
Data Management/Analysis.
For aims one and two, qEEG data were gathered from a sample of eight participants
and matched with their corresponding PCL-M and PSQI scores from before and after ART.
These data were used to assess the differences in self-reported sleep quality (PSQI), PostTraumatic Stress Disorder symptoms (PCL-M) and qEEG measures taken from Delta,
Theta, Alpha, Beta, and Gamma stages of sleep from before to after ART. The same data
were used to inform research question two, and quantify the correlational relationships
between self-reported (PSQI) and objective (qEEG) measures of sleep quality.
Descriptive statistics were calculated for the primary variables included in Aims 1 and
2. Continuous variables are expressed as mean ± standard deviation (SD); categorical
variables are presented as frequencies and percentages.
Aim # 1: Investigate the effects of ART on comorbid PTSD and sleep disturbances in
U.S veterans measured both subjectively (self- report) and objectively (sleep EEG data),
from previously collected pilot study data.
Hypothesis # 1: ART will be effective in improving both subjective and objective
measures of sleep disturbances in U.S veterans.
Normality. Prior to analysis, normality was assessed for each of the continuous sleep
measures using measures of skew and kurtosis for each continuous score. In addition, a
student’s t-test for location was conducted with the null hypothesis that the data are
centered on zero. Data are typically considered normal if they meet the following criteria
for normality: (a) a skew between -2.0 and 2.0, and (b) kurtosis between -7.0 and
7.1 (Kline, 2011). Next, data regarding the spread and central tendency were assessed for
both subjective (i.e., PCL-M and PSQI) and objective sleep measures (i.e., qEEG) before
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and after ART.
Paired t tests were used to examine the difference in subjective sleep quality (PSQI),
subjective PTSD symptoms (PCL-M), and objective sleep disturbances (qEEG) measures
from before to after ART. One dependent sample t-test was conducted on the self-reported
sleep quality (PSQI), one was conducted on self-reported PTSD symptoms (PCL-M), and
one was conducted on each stage of sleep measured from qEEG. This resulted in a series
of five dependent sample t-tests, with one for Delta, one for Theta, one for Alpha, one for
Beta, and one for Gamma.
Aim # 2: Assess the relationship between objective and subjective measures of sleep
disturbances before and after treatment with ART for symptoms of PTSD in U.S veterans,
from the previously collected pilot study data.
Hypothesis # 2: There will be a strong association between objective and subjective
measures of sleep disturbances in U.S. veterans before treatment with ART, after treatment
with PTSD, and based on treatment-related change in PTSD symptoms.
To assess the correlational relationship between measures of subjective sleep
disturbances (as measured by the qEEG), and subjective sleep quality (as measured by the
PSQI) before and after ART, a Pearson correlation matrix was created. Both objective and
subjective measurements were taken before and after ART was delivered, and a change
score was also calculated for each. Each time point was assessed for correlations with other
time points to determine if there were significant relationships. Change scores were also
created for this analysis, which measured the difference in each score from baseline to postART.
Any correlation with a coefficient of over .50 may provide insight into a correlation
that may be detected with a larger sample size (Tabachnick & Fidell, 2012). As such,
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correlations with an r coefficient of .50 or greater were further examined. An r coefficient
of .50 or greater indicates that 25% or more of the variance between two variables are
related (Pallant, 2010) and was chosen based on Cohen’s (1988) suggestion that this r
indicates a medium effect size.
Specific Aim # 3.
Design. Data were pooled from 2 completed studies of ART directed by Dr. Kip in
a secondary data analysis. The overall description for the 2 studies, one conducted in
civilians (n=75) and the other conducted in service members and veterans (n=50) were
treated for PTSD, are as follows:
Population. For the civilian study, a total of 97 persons were screened, of whom,
17 (17.5%) were determined to be ineligible for the study. Among the 80 enrolled
participants, 66 (82.5%) completed the full course of treatment including initial posttreatment assessment. For the military study, a total of 63 service members/veterans were
assessed for trial eligibility, of whom, 57 (90.5) were clinically eligible and enrolled.
Measures. For assessment of PTSD among veterans, the 17-item PCL-M (Military)
Checklist was used. This is a self-report instrument of DSM-IV symptoms of PTSD in
response to stressful military experiences, and is used with service members and veterans.
The 17-item PCL-C Checklist is the civilian version of the PTSD assessment, and was used
for data collected in the civilian study. Cronbach’s α reliability has been reported as 0.97
(Blanchard, 1996; King et al., 2013).
For assessment of sleep function, the 15-item self-report Pittsburgh Sleep Quality
Index (PSQI) developed in 1989 (Buysse et al., 1989) was used. The PSQI measures the
quality and patterns of sleep in adults. It takes approximately 3 to 6 minutes to complete. A
global PSQI score greater than five yielded a diagnostic sensitivity of 89.6% and specificity
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of 86.5% (kappa = 0.75, p less than 0.001) in distinguishing good and poor sleepers. A
score of >5 indicates a positive screening for sleep disturbance. The internal consistency
reliability coefficient (Cronbach’s alpha) has been reported as 0.88 (Farrahi, Nakhaee,
Sheibani, Garrusi, & Amirkafi, 2009).
Data Management/Analysis. To inform aim # 3, secondary data were gathered
from the two previous studies described above, and included a total of 125 observations.
These data were used to examine the relationship between self-reported PTSD symptoms
(PCL-M) and self-reported sleep quality (PSQI) among study participants who received
ART. Since the study hypothesis involved comparison of treatment response between
civilians and veterans, an initial step was to compare demographic and presenting clinical
characteristics between the 2 groups. This included use of student t-tests to compare
continuous variables and use of chi-square tests to compare categorical variables.
Civilian versus military status was used in stratified analyses. Pearson correlation
coefficients were calculated to examine the strength of association between self-report
scores on the PCL (PTSD) checklist and PSQI. These calculations were performed before
treatment with ART, after treatment with ART, at 3-month follow-up, and based on the
pre-to-post treatment change. This was followed by use of multiple linear regression
analysis. With this approach, the PSQI score served as the dependent variable with PCL
score as the primary independent variable, along with a main effect term for military
status (civilian vs. military) and an interaction term (military status x PCL score). The
interaction term (military status x PCL score) was included to examine whether the
relationship between PTSD score and PSQI varies (is modified) by military status.
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Chapter Four:
Results
Introduction
This chapter describes the results obtained for examination of the 3 specific aims
and 3 corresponding hypotheses. As with earlier chapters, the results are presented
separately for aims 1 and 2 (pilot study) and then for aim 3 (secondary data analysis).
Research Aim # 1: From previously collected pilot study data investigate the
effects of ART on comorbid PTSD and sleep quality in U.S veterans measured both
subjectively (self-report) and objectively (sleep EEG data).
Hypothesis # 1: ART will be effective in improving both subjective and objective
measures of sleep disturbances in U.S veterans.
Demographic and Clinical Presentation Characteristics
Table 1 provides descriptive characteristics for demographic and clinical presentation
variables that were measured on a continuous scale. As seen, the mean age was 37.6 + 6.5
years. The mean PSQI score was 14.5 + 4.4 which is much higher than the screening score
of >5 used to indicate impaired sleep function (Buysse, 1989). Similarly, the mean PCL-M
score of 63.7 + 10.4 was high given the potential score range on this instrument from 17 to
85. These high mean values for sleep disturbance and symptoms of PTSD reflect the study
inclusion criteria. In addition, the mean depression score of 28.9 + 9.2 was much higher
than the cutpoint of >16 used to indicate a possible diagnosis of depression (Radloff, 1997).
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Table 1. Descriptive Characteristics for Continuous Demographic and Clinical
Presentation Variables.
Variable

N

M

SD

Minimum

Maximum

8.00

37.63

6.50

28.00

47.00

8.00

14.50

4.38

7.00

20.00

8.00

63.75

10.44

46.00

78.00

8.00

55.63

6.95

46.00

66.00

8.00

31.00

11.59

14.00

46.00

baseline

8.00

28.88

9.23

14.00

41.00

Pain Scale (SF-36) at baseline

7.00

41.79

8.50

22.50

45.00

Age in years
Pittsburgh Sleep Quality Index
at baseline
PTSD Checklist (PCL-M)
Score at baseline
T-score of Psychiatric
Diagnostic Screening
Questionnaire at baseline
Raw Score Brief Symptom
Inventory (BSI) at baseline
Adjusted score Center for
Epidemiologic Studies
Depression Scale (CES-D) at

Table 2 provides descriptive characteristics for demographic and clinical
presentation variables that were measured categorically. As seen, the majority of study
participants were male, of white race, a discharged veteran, and had experienced combatrelated activity. Seven of the eight participants screened positive for depression at baseline,
along with a high prevalence of other comorbidities including generalized anxiety disorder,
and agoraphobia. The range of PSQI scores was 7 to 20, confirming that all participants
indicated impaired sleep function (i.e. PSQI score >5).
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Table 2. Frequencies and Percentages of Demographic and Clinical Presentation Variables.
Variable

n

%

Gender
Male
Female
Race
Black
White
Employment status
Full-time employment
Part-time employment
Unemployed or disabled
Other
Military status
Reservist
Discharged/veteran
Experience combat-related activity
No
Yes
Head trauma
No
Yes
Number of traumatic memories impacting life
1 to 2
3 to 4
5 or more
Currently on disability for PTSD/MH problem
No
Yes
Previous Treatment for PTSD
No
Yes
Prior Treatment –Psychotherapy
Yes
Screen Positive for PTSD (PDSQ) at baseline
No
Yes
Diagnosis of Depression by CES-D at baseline
No
Yes
Screen positive for Major Depressive Disorder Suicidality (PDSQ) at baseline
Yes
Screen Positive for Generalized Anxiety Disorder (PDSQ) at baseline
No
Yes
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7
1

87.50
12.50

1
7

12.50
87.50

5
1
1
1

62.50
12.50
12.50
12.50

2
6

25.00
75.00

1
7

12.50
87.50

7
1

87.50
12.50

1
3
4

12.50
37.50
50.00

4
4

50.00
50.00

1
7

12.50
87.50

8

100.00

1
7

12.50
87.50

1
7

12.50
87.50

8

100.00

2
6

25.00
75.00

Table 2 (Continued). Frequencies and Percentages of Demographic and Clinical Presentation Variables.
Variable
Screen Positive for Social Phobia (PDSQ) at baseline
No
Yes
Screen Positive for Somatization Disorder (PDSQ) at baseline
No
Yes
Screen Positive for Obsessive Compulsive Disorder (PDSQ) at baseline
No
Screen Positive for Panic Disorder (PDSQ) at baseline
No
Yes
Screen Positive for Agoraphobia (PDSQ) at baseline
No
Yes
Screen Positive for Hypochondriasis (PDSQ) at baseline
No
Yes
Screen Positive for Alcohol Abuse (PDSQ) at baseline
No
Yes
Screen Positive for Drug Abuse/Dependence (PDSQ) at baseline
No
Pittsburgh Sleep Quality Index at Baseline
7
11
16
17
18
20

n

%

3
5

35.50
62.50

4
4

50.00
50.00

8

100

5
3

62.50
35.70

1
7

12.50
87.50

6
2

75.00
25.00

7
1

87.50
12.50

8

100.00

1
2
2
1
1
1

12.50
25.00
25.00
12.50
12.50
12.50

Medication Use at Baseline. As seen in table 3, the 8 participants reported taking a
range of medications. In terms of major classification of medications, respective
percentages were: anti-anxiety (100%, anti-depressant (100%%), anti-seizure (20%), sleep
(100%), and pain (20%).

43

Table 3. Medications Taken at Baseline.
ID

Med 1

Med 2

Med 3

Med 4

Med 5

Med 6

1

Fluoxetine

Vitamin
B12

Lisinopril

Prazosin

Inhaler

Clotrimazol
e

2

Depoprevera

3

Hyroxidine

4

Prozozin

Citalopram

5

Cymbalta

Seraquel

Prazosin

Meloxicam

6

Seroquel

Celebrex

Hydrozine

Gabapentin

Tramadol

Mexazoin

7

Lipitor

Celexa

Buspar

Lamictal

Vitamin D3

8

Paxil

Celexa

Bubroxin

Lisinopril

Amlodine

Traziadone

Modafinil

Tricor

Viagra

Dexanphatamine

Oxycodone

Meloxicam

Med 7

Med 8

Nuvigil

Micardis

Abilify

Topomax

Tranadal

Tynelol

Assessment of Normality. As stated above, normality was assessed for each of the
continuous sleep measures. Only the baseline Beta 25-30 frequency measure had a skew
outside of conventional boundaries for normality, although, this variable had a kurtosis
well within the -7 to 7 boundaries. Each variable had a significantly different central
tendency from that of 0, as indicated by the series of t tests. After normalizing the sleep
measures, each qEEG score’s variance dropped to zero. Results of the assessment of
normality are presented in Tables 4 and 5. These data confirm appropriate use of
parametric analyses.
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Table 4. Normality Assessment for Continuous Sleep Measures at Baseline.
Sleep measure

Skew Kurtosis

Variance

t test for location

p-value

PSQI at baseline

-0.63

-0.62

19.14

9.37

.001

Delta 1.5 – 3.5 baseline

1.00

0.17

49030.08

8.50

.001

Theta 4-6.5 baseline

0.37

-0.74

9827.23

9.46

.001

Alpha 8-11 baseline

0.62

-1.35

146101.87

3.68

.001

Beta 12-15 baseline

0.65

-1.10

6888.37

5.10

.001

Beta 16-20 baseline

0.47

-1.95

1201.68

6.21

. 001

Beta 20-25 baseline

1.32

0.67

5602.21

3.36

.012

Beta 25-30 baseline

2.05

5.04

659.19

4.57

.003

Gamma > 30 baseline

1.51

3.37

95.55

5.84

.001

*Note. Student’s t test for location against the null hypothesis that µ0=0.
Mean Scores Before and After Treatment with ART. Descriptive data regarding
mean scores for both subjective (i.e., PCL-M and PSQI) and objective sleep measures (i.e.,
qEEG) before and after ART are presented in Tables 6 and 7. As seen in Table 6, the mean
PTSD (PCL-M) score decreased substantially from baseline (63.75) to post-treatment
(33.6), as did self-report PSQI scores (14.5 vs. 9.6). As seen in table 7, results were more
variable with mean values of different EEG wave frequencies apparently increasing or
decreasing after treatment with ART. Results for the normalized values of qEEG scores
were similar (data not shown).
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Table 5. Normality Assessment for Normalized qEEG Sleep Measures at Baseline
Normalized qEEG

Skew

Kurtosis

Variance

measure
Delta 1.5 – 3.5 baseline

t test for

p-value

location
-1.05

2.13

0.00

12.91

.001

Theta 4-6.5 baseline

0.80

-0.03

0.00

8.14

.001

Alpha 8-11 baseline

0.46

-1.12

0.00

5.37

.001

Beta 12-15 baseline

0.00

-1.27

0.00

8.28

.001

Beta 16-20 baseline

-0.55

-1.67

0.00

9.51

.001

Beta 20-25 baseline

0.98

0.11

0.00

4.66

.002

Beta 25-30 baseline

0.94

-0.85

0.00

5.95

.001

Gamma > 30 baseline

0.55

-1.50

0.00

7.59

.001

*Note. Student’s t test for location against the null hypothesis that µ0=0.
For formal testing of aim #1, a series of paired sample t-tests were conducted to
examine the difference in subjective sleep quality (PSQI), subjective PTSD symptoms
(PCL-M), and objective sleep quality (qEEG) measures from before to after ART.
Specifically, one dependent sample t-test was conducted on the self-reported sleep
quality (PSQI), one was conducted on self-reported PTSD symptoms (PCL-M), and one
was conducted on each stage of sleep measured from qEEG.
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Table 6. Mean PCL-M and PSQI Scores Before and After Treatment with ART.
Variable

M

SD

Min

Max

PTSD Checklist (PCL-M) Score at baseline

63.75

10.44

46.00

78.00

PTSD Checklist (PCL-M) Score post-treatment

33.63

13.34

17.00

56.00

Pittsburgh Sleep Quality Index at baseline

14.50

4.38

7.00

20.00

Pittsburgh Sleep Quality Index post-treatment

9.63

5.40

1.00

16.00

As seen in table 8, results indicated a significant improvement in self-reported sleep
quality (t(7) = 2.47, p = .043), as measured from the PSQI, and a significant reduction in
self-reported PTSD symptoms (t(7) = 9.70, p = .001). Of the objective sleep disturbances
data (qEEG), two sleep stages had significantly different readings from before to after
ART; these included increases in the frequency of Delta (t(7) = -2.67, p = .032) and Theta
(t(7) = -6.48, p < .001) waves. Alpha, Beta, and Gamma readings did not differ
significantly in their measures from before to after ART. In aggregate, the results suggest
that ART reduces symptoms of PTSD, improves subjective reported sleep quality, and
appears to increase the frequency of “slow” brain waves during a 30-minute nap protocol,
including Delta and Theta waves.
Aim Number Two
Research Aim # 2: From the previously collected pilot study data, assess the
relationship between objective and subjective measures of sleep quality before and after
treatment with ART for symptoms of PTSD in U.S veterans.
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Table 7. Mean qEEG Scores Before and After Treatment with ART (Non-Normalized).
Variable

M

SD

Min

Max

Delta_15_35_Pre

665.26

221.43

444.17

1082.04

Delta_15_35_Post

965.15

340.58

612.60

1394.78

Theta_4_65_Pre

331.52

99.13

198.74

494.48

Theta_4_65_Post

414.59

106.46

296.45

593.82

Alpha_8_11_Pre

497.22

382.11

126.99

1114.44

Alpha_8_11_Post

566.65

586.08

164.65

1837.42

Beta_12_15_Pre

149.52

83.00

51.98

275.91

Beta_12_15_Post

210.46

221.50

69.33

748.08

Beta_16_20_Pre

76.11

34.67

39.40

121.12

Beta_16_20_Post

108.82

76.92

39.47

275.14

Beta_20_25_Pre

88.78

74.85

23.29

232.29

Beta_20_25_Post

132.77

154.14

30.17

486.97

Beta_25_30_Pre

41.48

25.67

18.84

100.46

Beta_25_30_Post

41.51

26.43

21.71

99.89

Beta_gt_30_Pre

35.69

17.28

17.32

73.05

Beta_gt_30_Post

30.57

14.24

17.65

61.23

Hypothesis # 2: There will be a strong association between objective and
subjective measures of sleep disturbances in U.S. veterans before treatment with ART, after
treatment with PTSD, and based on treatment-related change in PTSD symptoms.
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Table 8. Paired Sample t-Test for Pre-ART to Post-ART Measures of Sleep Function and
PTSD.
Confidence

ΔM
Measure

(pre

SD

SE

to
PSQI
PCL-M

interval

t(7)

Lower

Upper

p

post)
-4.88*

5.59

1.98

0.20

9.55

2.47

.043

-30.13***

8.79

3.11

22.78

37.47

9.69

.001

-565.31

-34.47

-2.67 .032

Delta: 1.5 – 3.5 Hz

299.89*

Theta: 4 – 6.5 Hz

83.07***

317.48 112.25
36.24

12.81

-113.36

-52.77

-6.48 .000

Alpha: 8 – 11 Hz

69.43

621.43

219.71

-588.96

450.09

-0.32 .761

Beta: 12 – 15 Hz

60.94

170.9

60.41

-203.80

113.00

-1.01 .347

Beta: 16 – 20 Hz

32.71

65.28

23.08

-87.28

43.16

-1.42

.199

Beta: 20 – 25 Hz

43.99

101.90

36.01

-129.10

67.34

-1.22

.261

Beta: 25-30 Hz

43.99

101.86

36.01

-129.15

41.17

-1.22

.261

Gamma: > 30 Hz

-5.12

7.87

2.78

-1.46

11.70

1.84

.109

*Note. *p<0.05; **p<0.01; ***p<0.001
To assess the correlational relationship between measures of subjective sleep
disturbances (as measured by the qEEG), and subjective sleep quality (as measured by the
PSQI) before and after ART, a correlation matrix was created. Both objective and
subjective measurements were taken before and after ART were gathered, and a change
score was also calculated for each. Descriptive statistics for these change scores are
presented in Table 9.
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Table 9. Descriptive Statistics of Change from Baseline for qEEG and PSQI.
Variable

N

Change in Delta 1.5-3.5 Hz

8

Change in Theta 4-6.5 Hz

M

SD

Sum

Minimum

Maximum

-299.89 317.48 -2399.00

-829.04

125.35

8

-83.07

36.24

-664.53

-129.02

-31.49

Change in Alpha 8-11 Hz

8

-69.43

621.43

-555.47

-1057.00

872.83

Change in Beta 12-15 Hz

8

-60.94

170.86

-487.55

-472.17

57.95

Change in Beta 16-20 Hz

8

-32.71

65.28

-261.66

-154.02

51.30

Change in Beta 20-25 Hz

8

-43.99

101.86

-351.93

-254.68

75.79

Change in Beta 25-30 Hz

8

-0.02

8.19

-0.20

-12.52

11.58

Change in Beta > 30 Hz

8

5.12

7.87

40.95

-6.35

14.82

Change in PSQI

8

4.87

5.59

39.00

-1.00

15.00

Baseline (Pre-ART) Correlations. Table 10 presents the Pearson correlation
coefficients between qEEG scores measured at baseline (pre-ART) and self-report PSQI
score at baseline. As seen, there were significant, strong inverse correlations between selfreport PSQI scores and Delta and Alpha brain wave activity prior to treatment with ART.
Given the sample size of 8 subjects, it should be noted that a typical Pearson
Correlation with a power of .80 to reject a false null requires approximately 81
observations (Faul, Erdfelder, Buchner, & Lang, 2012). Thus, any correlation with a
coefficient of over .50 may provide insight into a correlation that may be detected with a
larger sample size (Tabachnick & Fidell, 2012) and may be meaningful and represent a
“medium” effect (Pallant, 2010, Cohen, 1988). In this realm, the correlation coefficient
between self-report PSQI score at baseline and Beta 16-20 Hz at baseline was 0.50.
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Table 10. Pearson Correlations between qEEG and PSQI at Baseline.
qEEG at baseline

PSQI at baseline

Delta 1.5-3.5 Hz at baseline

-0.79*

Theta 4-6.5 Hz at baseline

-0.45

Alpha 8-11 Hz at baseline

-0.89**

Beta 12-15 Hz at baseline

-0.40

Beta 16-20 Hz at baseline

-0.50

Beta 20-25 Hz at baseline

-0.31

Beta 25-30 Hz at baseline

0.01

Beta > 30 Hz at baseline

-0.04

*p < 0.05; **p < 0.01
Post-ART Correlations. Table 11 presents the Pearson correlation coefficients
between qEEG scores measured after completion of treatment with ART and self-report
PSQI score after ART. Unlike the results from the baseline assessment, self-report PSQI
scores after treatment with ART were inversely associated with Theta wave activity after
treatment with ART. There were non-significant trends for higher PSQI scores after
treatment with ART to be associated with higher Beta wave activity. Collectively, the
baseline and post-ART correlation results seem to suggest that higher PSQI scores are
associated with lower slow wave (Delta and Theta) activity, and that higher PSQI scores
seem to be associated with higher Beta wave activity.
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Table 11. Pearson Correlations between qEEG and PSQI Post ART.
qEEG after ART

PSQI post ART
0.03

Delta 1.5-3.5 Hz post ART
Theta 4-6.5 Hz post ART

-0.75*

Alpha 8-11 Hz post ART

0.25

Beta 12-15 Hz post ART

0.47

Beta 16-20 Hz post ART

0.66

Beta 20-25 Hz post ART

0.58

Beta 25-30 Hz post ART

0.60

Beta > 30 Hz post ART

0.57

*p < 0.05
Pre-ART to Post-ART Change Correlations. Table 12 presents the Pearson
correlation coefficients between qEEG change (pre-ART to post-ART) and PSQI change
scores. There were no significant associations and all correlation coefficients were below a
value of 0.50.
PCL-M and qEEG. Given the suggestion that higher PSQI scores (poorer sleep
quality) may be associated with lower slow wave brain activity, parallel analyses were
conducted to examine whether higher PTSD scores may be associated with lower slow
wave brain activity. Table 13 (see below) presents the Pearson correlation coefficients
between qEEG scores measured at baseline (pre-ART) and self-report PTSD score (PCLM) at baseline. There were no significant associations, although there was a suggestion that
higher PCL- M scores were associated with higher Beta 25-30 Hz activity (r=0.55, p=0.16).
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Table 12. Pearson Correlations between Changes from Baseline for qEEG and PSQI.
Change in qEEG

Change in PSQI

Change in Delta 1.5-3.5 Hz

0.21

Change in Theta 4-6.5 Hz

-0.30

Change in Alpha 8-11 Hz

0.17

Change in Beta 12-15 Hz

0.11

Change in Beta 16-20 Hz

0.30

Change in Beta 20-25 Hz

0.26

Change in Beta 25-30 Hz

-0.02

Change in Beta > 30 Hz

-0.41

Table 13 results are consistent with the baseline (pre-ART results). There were no
significant associations between post-ART qEEG scores and post-ART PCL-M scores in
table 14 (see below). However, there were suggestions of higher PCL-M scores after
treatment with ART being associated with higher Beta wave activity.
Finally, there were no significant associations between qEEG change scores and
PCL-M change scores in table 15 (see below). Thus, in aggregate, there was minimal
evidence of a relationship between PTSD (PCL-M) scores and qEEG scores.
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Table 13. Pearson Correlations between qEEG and PCL-M at Baseline.
Baseline qEEG

Baseline PCL-M

Delta 1.5-3.5 Hz at baseline

-0.23

Theta 4-6.5 Hz at baseline

-0.20

Alpha 8-11 Hz at baseline

-0.12

Beta 12-15 Hz at baseline

0.21

Beta 16-20 Hz at baseline

0.34

Beta 20-25 Hz at baseline

0.40

Beta 25-30 Hz at baseline

0.55

Beta > 30 Hz at baseline

0.38

Table 14. Pearson Correlations between qEEG and PCL-M Post ART.
qEEG post ART

PCL-M post ART

Delta 1.5-3.5 Hz post ART

0.48

Theta 4-6.5 Hz post ART

-0.44

Alpha 8-11 Hz post ART

0.04

Beta 12-15 Hz post ART

0.36

Beta 16-20 Hz post ART

0.58

Beta 20-25 Hz post ART

0.51

Beta 25-30 Hz post ART

0.50

Beta > 30 Hz post ART

0.49
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Aim Number Three
Research Aim # 3: In a secondary data analysis from two previously conducted
studies, compare self-report PTSD and sleep disturbance symptoms between civilians and
veterans before and after treatment with ART.
Hypothesis # 3: Civilians and veterans will report similar self-report PTSD and
sleep disturbance symptoms before and after treatment with ART.
Table 15. Pearson Correlations between Changes from Baseline for qEEG and PCL-M.
Change in qEEG

Change in PCL-M

Change in Delta 1.5-3.5 Hz

0.38

Change in Theta 4-6.5 Hz

-0.39

Change in Alpha 8-11 Hz

-0.13

Change in Beta 12-15 Hz

-0.18

Change in Beta 16-20 Hz

0.00

Change in Beta 20-25 Hz

0.01

Change in Beta 25-30 Hz

-0.17

Change in Beta > 30 Hz

-0.35

Comparison of Baseline Demographic Characteristics by Military Status. As
seen in table 16, the mean age of the 125 participants included in the secondary analysis
was 41.0 + 11.1 years. Of note, the mean age was similar between military and civilian
participants enrolled in the two studies.
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Table 16. Independent Sample t-test for Demographic Characteristics by Military Status.
Variable

Total Sample (n = 125)

Age

Military (n = 50)

Civilian (n = 75)

M

SD

M (SD)

SD

M

SD

t(123)

p

40.98

11.07

41.92

12.75

40.35

9.84

-.78

.439

As seen in table 17, the majority of participants in the civilian study (80.0%) were
female compared to only 18% in the military study (p<0.001). In addition, the civilian
study had higher representation of those with Hispanic ethnicity compared to the military
study.
Table 17. Chi-Square Analyses between Categorical Demographical Variables and
Military Status.
Military

Civilian

N (%)

N (%)

N (%)

125

50

75

χ2(1)

p

Female gender

69 (55.2)

9 (18.0)

60 (80.0)

46.63

<0.001

Hispanic ethnicity

26 (21.1)

6 (12.0)

20 (27.4)

4.22

0.04

Married

72 (57.6)

29 (58.0)

43 (57.3)

0.01

0.94

Sexual trauma

26 (20.8)

7 (14.0)

19 (25.3)

2.34

0.13

Employed

72 (59.0)

29 (58.0)

43 (59.7)

0.04

0.85

Variable
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Comparison of Baseline Clinical Characteristics by Military Status. Table 18
shows mean PCL and PSQI scores at the 3 time points consisting of baseline (time 1), postART (time 2), and at 3-month follow-up (time 3). At baseline, the mean PCL score was
similar between military and civilian participants (56.1 vs. 54.2, p=0.43). However, when
examining the 4 PTSD subscales at baseline, military participants presented with higher
levels of arousal compared to civilian participants (18.0 vs. 15.0, p=0.002). After treatment
completion with ART, the mean PCL score was lower in civilian participants compared to
military participants (30.7 vs. 40.7, p=0.004). However, at 3-month follow- up, scores were
similar (30.0 vs. 33.1, p=026, respectively).
At baseline, military participants presented with higher mean PSQI scores (12.6 vs.
9.4, p=0.002). This relative difference persisted after treatment with ART (9.9 vs. 6.7,
p=0.001) and with a trend at 3-month follow-up (8.8 vs. 6.7, p=0.08).
Table 18. Independent Sample t-Test for Clinical Characteristics by Military Status.
Total Sample
(n=125)

Military
(n=50)

Civilian
(n=75)
t

p

Variable
M
SD
M
SD
M
SD
Scores at three times (1=Baseline, 2=post ART, 3=3 month follow-up)
PCL1 (n = 125)

54.9

13.8

56.1

15.3

54.2

12.7

-0.79

0.431

PCL2 (n = 113)

34.9

15.1

40.7

17.8

30.7

11.2

-3.67

0.004

PCL3 (n = 91)

31.3

12.6

33.1

12.7

30.0

12.4

-1.14

0.26

PSQI1 (n = 119)

10.7

4.7

12.6

4.3

9.4

4.4

-3.90

0.002

PSQI2 (n = 101)

8.1

4.9

9.9

4.8

6.7

4.6

-3.37

0.001

PSQI3 (n = 79)
7.5
4.9
PTSD (PCL) subscales – at baseline

8.8

5.5

6.7

4.5

-1.80

0.08

16.0
6.8
18.0
15.3

5.2
2.5
4.6
5.7

16.4
6.5
15.0
16.2

4.2
2.2
5.6
4.7

0.46
-0.85
-3.13
0.98

0.64
0.40
0.002
0.33

Intrusion
Avoidance
Arousal
Numbing

16.2
6.6
16.2
15.9

4.6
2.4
5.4
5.1
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Pearson Correlations between PCL and PSQI Stratified by Military Status.
PCL and PSQI at Time 1 (Baseline).
Pearson Correlation for PCL1 and PSQI1. Among civilian participants, there
was a strong association between PCL and PSQI scores at baseline (r = 0.62, p < 0.0001).
These data are depicted in the scatterplot presented in Figure 4 (left side). Among military
participants, there was a modest association between PCL and PSQI scores at baseline (r =
0.48, p = 0.0004). These data are depicted in the scatterplot presented in Figure 4 (right
side).

Figure 4. Scatterplot between PCL and PSQI at baseline (civilians left, military right)
Pearson Correlation for PCL2 and PSQI2. Among civilian participants, there
was a strong association between PCL and PSQI scores after treatment completion with
ART (r= 0.66, p < 0.0001). These data are depicted in the scatterplot presented in Figure 5
(left side). Among military participants, there was a similar strong association between
PCL and PSQI scores after treatment completion with ART (r = 0.59, p <0.0001). These
data are depicted in the scatterplot presented in Figure 5 (right side).
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Figure 5. Scatterplot between PCL and PSQI after Treatment Completion (civilians left,
military right)
Pearson Correlation for PCL3 and PSQI3. Among civilian participants, there
was a strong association between PCL and PSQI scores at 3-month follow-up (r = 0.66, p <
0.0001). These data are depicted in the scatterplot presented in Figure 6 (left side).
Among military participants, there was a similar strong association between PCL and PSQI
scores at 3-month follow-up (r = 0.71, p <0.0001). These data are depicted in the scatterplot
presented in Figure 6 (right side).

Figure 6. Scatterplot between PCL and PSQI at 3-Month Follow-up (civilians left, military
right)
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Thus, results of the association between PCL and PSQI scores were relatively
consistent between veterans and civilians. This included a strong association being
present at all three time points.
Pearson Correlation Between Change in PCL and Change in PSQI Overall
and by Military Status. The change in PCL and PSQI scores from before to after
treatment with ART was calculated overall and by military status. Among all participants,
there was a modest association between change in PCL and change in PSQI scores (r =
0.38, p < 0.0001). The scatterplot for these data are depicted in Figure 7.

Figure 7. Scatterplot between change in PCL and change in PSQI (total sample)
Among civilian participants, there was also a modest association between change in
PCL and change is PSQI scores (r = 0.43, p = 0.001). These data are depicted in the
scatterplot presented in Figure 8 (left side). Among military participants, there was a
similar modest association between change in PCL and change in PSQI scores (r = 0.40, p
=0.009). These data are depicted in the scatterplot presented in Figure 8 (right side).
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Figure 8. Scatterplot between change in PCL and change in PSQI scores (civilians left,
military right)
Multiple Linear Regression Analysis.
As seen in Table 19, at baseline, PCL score was a strong predictor of PSQI score (t
= 6.3, p<0.001). Military status was also associated with PSQI score at baseline (t = 2.7,
p=0.009). However, the interaction between PCL score and military status was not
significant (p=0.10). The model R2 value of 0.40 suggests that PCL score, military status,
and the interaction between the two accounted for 40% of the variance in PSQI score at
baseline. For interpretation, each unit increase in PCL score at baseline was associated with
an estimated increase in PSQI score of 0.22 points. Compared to civilian status, being a
military member indicated a 7.4-point higher score on the PSQI at baseline.
Table 19. Results of Multiple Linear Regression with PCL and Military Status Predicting
PSQI Score at Baseline.
Source

B

SE

β

t

p

PCL score

0.22

0.03

.64

6.31

<0.001

Military member

7.38

2.77

.78

2.67

.009

PCL*Military

-0.08

0.05

-.50

-1.64

.103

*Note. F(3, 115) = 25.96, p < .001, R2 = .40

61

The above regression analysis was replicated based on scores obtained at the
completion of treatment with ART (time 2). As seen in Table 20, PCL score again was a
strong predictor of PSQI score (t = 6.3, p<0.001). Military status was also associated with
PSQI score after completion with ART (t = 2.3, p=0.02). Again, the interaction between
PCL score and military status was borderline significant (p=0.07). The model R2 value of
0.46 suggests that PCL score, military status, and the interaction between the two
accounted for 46% of the variance in PSQI score after treatment completion with ART. For
interpretation, each unit increase in PCL score after treatment with ART was associated
with an estimated increase in PSQI score of 0.27 points. Compared to civilian status, being
a military member indicated a 4.7-point higher score on the PSQI after treatment with
ART.
Table 20. Results of Multiple Linear Regression with PCL and Military Status Predicting
PSQI Score After Treatment Completion with ART.
Source

B

SE

β

t

p

PCL2

0.27

0.04

.80

6.29

<.001

Military Status

4.71

2.06

.47

2.29

.024

PCL2*Military Status

-0.10

0.06

-.46

-1.83

.070

*Note. F(3, 97) = 27.75, p < .001, R2 = .46
Table 21 provides results for the regression analysis for scores obtained at 3-month
follow-up. As seen in Table 21, PCL score again was a strong predictor of PSQI score (t=
5.7, p<0.001). However, military status was not associated with PSQI score at 3-month
follow-up (t = -0.4, p=0.68), and the interaction between PCL score and military status was
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not significant (p=0.32). The model R2 value of 0.49 suggests that PCL score, military
status, and the interaction between the two accounted for 49% of the variance in PSQI
score at 3-month follow-up.
Table 21. Results of Multiple Linear Regression with PCL and Military Status Predicting
PSQI Score Sat 3-Month Follow-up.
Source

B

SE

β

T

p

PCL3

0.24

0.04

.61

5.72

<.001

Military Status

-0.95

2.32

-.09

-0.41

.684

0.07

0.07

.25

1.00

.321

PCL3*Military Status

*Note. F(3, 75) = 24.27, p < .001, R2 = .49
Finally, the analysis was replicated using change in PCL and PSQI scores from
baseline to treatment completion with ART. As seen in Table 22, change in PCL score after
treatment completion with ART was a strong predictor of change in PSQI score (t = 2.9,
p=0.003). Military status was not associated with change in PSQI score (t = -0.30, p=0.77),
and the interaction between change in PCL score and military status was not significant
(p=0.52)
Table 22. Results of Multiple Linear Regression with Change in PCL and Military Status
Predicting Change in PSQI Score.
Source

B

SE

β

t

p

Change in PCL (T2-T1)

0.10

0.03

.37

2.92

.004

Military Status

-0.35

1.19

-.05

-0.30

.767

Change in PCL*Military Status

0.03

0.05

.10

0.64

.522

*Note. F(3, 75) = 24.27, p < .001, R2 = .49
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In aggregate, the results of the regression analyses indicated that PCL score was
strongly associated with PSQI score at all time points, and that military status (compared to
civilian status) was generally associated with higher PSQI scores. The interaction between
PTSD score and being a military member was non-significant in all models, suggesting a
relatively similar relationship between symptoms of PTSD and sleep quality between both
civilians and veterans.
Magnitude of Acute and Sustained Changes
The magnitude of change in PCL and PSQI scores was examined as acute changes
(i.e., from pre-ART treatment to immediately post-treatment) and as sustained changes
(i.e., from pre-ART treatment, to three months following the treatment). The average acute
change on the PCL checklist was a reduction of 19.6 points, whereas the average acute
change on the PSQI was a reduction of 2.3 points. Sustained changes for the PCL were an
average reduction of 22.9 points, whereas average sustained changes for the PSQI were a
reduction of 2.6 points. Thus, the magnitude of change was relatively similar immediately
following treatment completion and at 3-month follow-up.
For veterans, the mean acute PCL change was 14.3 + 12.7 points. Among civilians,
the corresponding mean acute PCL change was 23.3 + 13.1 points. By use of a student ttest, the magnitude of acute PCL change was significantly greater in civilians compared to
veterans (t=3.64, p=0.0004). For sustained change, the difference by military status was
less pronounced. The mean sustained PCL change among veterans was 20.6 + 13.8 points
compared to 24.5 + 12.4 points among civilians. By use of a student t-test, the magnitude of
sustained PCL change was similar between civilians and veterans (t=1.40, p=0.16).
Finally, for veterans, the mean acute PSQI change was 2.5 + 4.1 points. Among
civilians, the corresponding mean acute PSQI change was 2.2 + 3.0 points. By use of a
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student t-test, the magnitude of acute PCL change was similar between veterans and
civilians (t=-0.41, p=0.68). For sustained change, the mean PSQI change among veterans
was 3.2 + 4.3 points compared to 2.0 + 3.4 points among civilians. By use of a student ttest, the magnitude of sustained PCL change was similar between civilians and veterans
(t=-1.28, p=0.21).
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Chapter Five
Discussion, Conclusions, and Recommendations
Introduction
The final chapter of this dissertation includes a synthesis of the results from the
study with discussion of the findings, conclusions, and implications for nursing and future
research recommendations. The focus of this dissertation was to examine the effects of
Accelerated Resolution Therapy (ART) on comorbid PTSD and sleep disturbances. This
included examination of both subjective and objective measurement of sleep data (U.S.
veterans), in addition to examination of results by military versus civilian status. The study
was carried out using 2 data sources and approaches. For specific aims 1 and 2, data from a
previously completed pilot study among eight U.S. veterans that included objective sleep
EEG data were analyzed. For aim 3, a secondary data analysis was conducted between 2
prior treatment studies of ART, which included extensive self- report data on symptoms of
PTSD and sleep disturbances. All three specific aims were analyzed considering pretreatment data, post-treatment data, and change in symptom and EEG measurements as a
result of participants being treated with ART.
Summary of the Results
Aim #1. The primary hypothesis for aim #1 was that treatment with ART would be
effective in improving both subjective and objective measures of sleep disturbances in U.S
veterans. Objective measurement of sleep quality was based on EEG analysis of brain wave
activity based on a 30-minute nap protocol conducted prior to treatment with ART and
after treatment completion with ART. From this pilot study of 8 U.S. veterans treated with
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ART, there was confirmatory evidence that ART resulted in improved subjective reported
sleep quality, in addition to evidence of increased Delta and Theta waves which are in the
frequency of “slow” brain waves. Despite the small sample of just 8 veterans,
improvements in subjective and objective measures of sleep achieved statistical
significance. Thus, these data provide supporting evidence that when ART is used as a
primary treatment for PTSD, corresponding improvements in sleep quality measured using
different approaches may be expected to occur.
Aim #2. The primary hypothesis for aim #2 was that subjectively reported
measurement of sleep function would be associated with EEG-objective measures of sleep
function before treatment with ART, after treatment with ART, and based on treatmentrelated change in PTSD symptoms. Relatively consistent with the results of aim #1, there
was evidence of significant, strong inverse associations between self-report (PSQI) scores
and Delta brain wave activity prior to treatment with ART. After treatment with ART, there
were non-significant trends for higher PSQI scores after treatment with ART to be
associated with higher Beta wave activity. Taking these results together, it appears that
higher (worse) self-report sleep scores (PSQI) are associated with less frequent slow wave
(Delta) activity, and that higher PSQI scores seem to be associated with higher Beta wave
activity. These results are in the expected direction (i.e. poorer self-report sleep quality
associated with less frequent “slow wave” and more frequent “fast wave” frequency).
However, there were no significant associations between qEEG change (pre-ART to postART) and PSQI change scores or qEEG change scores and PCL-M change scores. These
results indicate that objective (EEG) measurement of sleep disturbances following
treatment for PTSD does not correlate directly with self-report symptoms of sleep
disturbances or PTSD.
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Aim #3. The primary hypothesis for aim #3 was that civilians and veterans would
report similar self-report PTSD and sleep disturbances symptoms before and after
treatment with ART. As hypothesized, there were modest to large, statistically significant
correlations between self-reported PCL (PTSD) and PSQI (sleep) scores observed among
both civilians and veterans. These associations with present at baseline, immediately after
treatment completion with ART, at 3-month follow-up, and based on change in scores from
pre-treatment to post-treatment. In multiple regression analysis, change in PCL (PTSD)
score was a strong predictor of change in PSQI (sleep) score, irrespective of military versus
civilian status. Thus, even though military members tended to present with higher (worse)
PSQI scores at baseline, treatment with ART and reductions in PTSD were associated with
comparable reductions (improvement) in PSQI scores for both civilians and veterans.
Scientific Implications of Findings
Aim #1. When ART is used as a primary treatment for PTSD, consistent
improvements in sleep disturbances were observed using subjective and objective methods
and among both civilians and veterans. Other methods that may be used to examine
objective and subjective sleep quality include use of actigraphy and sleeping diaries (King,
Spence, Hickey, Sargent, Elesh, and Connelly, 2015). Both subjective and objective
measurements play important roles in estimating sleep disturbances and should be
incorporated in clinical studies to help address sleep disorders (Lin Zhang, 2007).
Aim # 2: Results indicate that objective or EEG measurements of sleep
disturbances after treatment for PTSD may not correlate directly with self-report symptoms
of sleep disturbances or PTSD. Recent findings suggest that objective measurements of
sleep function (EEG) may not as effective in capturing manifestations of changes in
subcortical circuits during REM and NREM sleep that may contribute to PTSD reliability
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(Germain, 2013). However, sleep diaries can be a relatively effective sleep measurement
approach (Germain, 2013). Sleep disturbances are considered a hallmark of PTSD, and the
present study examined EEG measurements in relation to PTSD and subjective
measurement of sleep quality. Human and animal studies have provided evidence for years
supporting the notion that sleep plays an important role in PTSD-relevant emotion and
memory processing for brain. Sleep diaries and other vigorous objective measurements
suggest REM sleep disturbances are implicated in PTSD, and that multiple measurement
methods should be used (Germain, 2014).
Aim # 3: Military members presented with higher or worse PSQI scores than
civilians at baseline. However, treatment with ART resulted in relatively comparable
reductions in symptoms of PTSD as well as reductions (improvement) in PSQI scores for
both civilians and veterans. These findings are consistent with earlier work showing that
veterans and civilians with PTSD have more severe sleep disturbances than those without
trauma (Lewis, Creamer & Failla, 2009).
Implications for Nursing
Whereas additional empirical research is needed in this area, the nurse caring for
the individual with PTSD, whether civilian or military, needs to routinely assess sleep
disturbances and initiate an open dialogue regarding these conditions. This rapport can
make it easier for patients to understand their current symptom experience and address
ways in which to heal and maximize wellness. In return, the nurse will be able to provide
the patient with the resources needed to help them better understand and address these
concerns, including after experiencing restless nights of sleep. While multiple authors
(Schoenfeld (2012), Harvey & Bryant (1998); Mellman, David, Bustamante, Torres, &
Fins (2001); Koren, Arnon, Lavie, & Klein (2002)) have shown that sleep disturbances
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may play a central role in future predicting development of PTSD after exposure to trauma,
this also corroborates the need for nurse to be attentive to sleep dysfunction, and the
possibility that it may be largely a consequence of recent trauma exposure and early
manifestation of PTSD. The presumed bi-directional temporal relationship between PTSD
and sleep disturbances places a premium on assessing these conditions collectively, rather
than as discrete, independent clinical conditions.
Limitations
Most importantly, there was no control group to compare the results achieved with
ART. This uncontrolled pilot study design is standard for an early stage evolving therapy
such as ART, but can provide suggestion of effectiveness. Second, for aims 1 and 2, there
was a very small sample size of eight participants in the study limiting precision of results.
In addition, having seven men and one woman in the aim 1 and 2 analyses limits
generalizability, as does the imbalance in aim 3 of having 80% women in the civilian
sample compared to 18% in the veterans sample.
Recommendations for Future Study
Based on the existing scientific literature in this area and the findings of the current
study, the following are future research recommendations.
1.

To continue to examine objective measures of sleep function (in the presence and

absence of PTSD) that are non-invasive, provide routine monitoring and export of data,
and track very closely with clinical diagnosis and self-report of sleep quality. The EEG
approach used in the present study, while useful from a scientific perspective, is not
practical for everyday objective monitoring of sleep function. Future studies with an
actigraphy will likely be more useful.
2.

Establish a clinical recommendation for nurses and advanced practice nurses to
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identify those who may be more likely to have sleep disturbances in conjunction with
symptoms of PTSD, and therefore, would derive the most benefit from screening and
intervention for these symptoms.
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Appendix A:
ART Intake Questionnaire
1) About how many traumatic memories are still impacting your life?
□ None
□ 1 to 2
□ 3 to 4
□ 5 or more
Which traumatic memory/memories would you like to resolve with A.R.T.?

2) Are you currently on disability for post-traumatic stress disorder (PTSD) or any
mental health problem?
□ YES □ NO
3) Do you feel that you are ready to let go of your traumatic memories so that you no
longer could see them in the same way (i.e. if there was a way to do this)?
□ YES □ NO
If No, what would prevent you from wanting to let go?

4) Is there any guilt associated with your traumatic memory or memories?
□ YES □ NO
If Yes, can you briefly explain what the guilt is about?

5) How long have you lived with the traumatic memory or memories?
□ 0-3 months □ 4 to 6 months
□ 7 to 12 months
□ 1 to 3 years □ 4 to 6 years □ 7 to 10 years□ 11+ years
6) I am motivated to move forward in my life:
Least motivated = 0
0

1

2

Most motivated = 10
3

4

5

6

(Please circle your answer)
7

8

9

7) Have you been diagnosed with any mental health conditions in the past?
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10

□ YES □ NO
If Yes, what is the condition or conditions?
8) What other problems are impacting your life now beside the traumatic memories
and other symptoms related to PTSD?

9)If you were able to rid yourself of the symptoms that occur from your traumatic
memories, what percentage of your mental health problems would be resolved (circle
one number)?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
--------------------------------------------------------------------------------------Name of therapist reviewing form:
Signature of therapist:
Today’s Date:
Page 2 of 2

97

100%

Appendix B:
Medical History Form

ID#
Date:

Visit:
Medical History Form
Page 1 of 2

1) Current and Past Medical History (check all that apply)
Diabetes
Cancer
Problems
Lung disease
Thyroid Problem
Intestinal Disorder
Kidney Disease
Liver Disease
Heart Disease
Neurological problems
Seizures
High Blood Pressure
problems, if female
Hearing Problems
Spinal cord Injury
burns
Head trauma
Paralysis (if yes, check all that apply)
Upper extremity(ies)
Lower extremity(ies)

Vision

Muscle/bone
GYN
Severe

Amputation (if yes, check below all that apply)
Lower limb(s)
Upper limb(s)
Lower extremity(ies)
Upper extremity(ies)
2) Have you previously received any treatment for Post-Traumatic Stress Disorder or
any other type of mental health condition?
Yes
No
If yes, please specify:
If applicable, what type of treatment(s) did you receive (check all that applies):
Individual therapy with a mental health professional
Type of therapy (check all the apply)
Psychotherapy:
Cognitive Behavior (CBT)
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Months of Treatment:
Group Psychotherapy

Months of Treatment:

Individual Psychotherapy

Months of Treatment:

Prolonged Exposure

Months of Treatment:

Eye Movement desensitization and reprocessing (EMDR)
Months of Treatment:
Prescription Medication

Months of Treatment:

Other (Please
specify)
3.) Please list the names of any prescription medications you are currently taking:
Medication name

Dose (if known)

Frequency (e.g. daily)
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Appendix C:
State – Trait Inventory for Cognitive and Somatic Anxiety
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Appendix D:
PTSD Checklist – Military Version (PCL – M)

101

Appendix E:
Demographics
ID #
Date:

Visit:
DEMOGRAPHICS (Page 1 of 2)

Please complete the following information. This information is only for research staff
reference and will remain strictly confidential.
1.) What is your age?
2.) Please indicate your gender:

A) Male

3.) Please indicate your race:
A) Black or African America
B) White
Native
C) Asian

B)Female

D) Native Hawaiian/Pacific Islander
E) American Indian/Alaskan

4.) Please indicate your ethnicity:
A) Non-Hispanic
B) Hispanic
5.) What is your current marital status? (Circle one)
A) Never married
D) Divorced or separated
B) Married
E) Widowed
C) Living with someone but not married
6.) What is your current employment status? (Circle One)
A) Full-time employment
E) Unemployed, disabled
B) Part-Time employment
F) Retired due to pain
C) Unemployed, not interested
G) Retired not due to pain
D) Unemployed, looking for work
H) Other (specify):
7.) How many years of education have you completed starting with the first grade?
Years
8.) Are you currently enrolled in an educational program?
A) Yes B) no C) I am planning to be
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ID#
Date:

Visit:
DEMOGRAPHICS (Page 2 of 2 )

9.) If you answered Yes to #8, what type of educational program are you enrolled in?
A) High School (GCSE, etc)
B) Vocational School
C) College/Associate Level degree
D) College/bachelors Level degree
E) College/Graduate Level Degree
F) Other
10.) What is your current military status? (Circle one)
A) Active Duty B) Reservist
C) Discharged/Veteran
11.) What branch of the military have you primarily served in? (Circle one)
A) Army
E) Marine Corps
I) Coast Guard
B) Army Reserves
F) Marine Corps Reserves
J) Coast Guard
Reserves
C) Navy
G) Air Force
K) National Guard
D) Naval Reserves H) Air Force Reserves
L) National Guard
Reserves
12.) How many overseas tours of duty have you had since joining the military?
(Circle one)
A) 1 B) 2
C) 3 D) 4 or more
13.) Where were you deployed? (Circle all that apply.)
A) Persian Gulf
D) Vietnam
B) Iraq
E) Kosovo
C) Afghanistan
F) Other
13a) Length of deployment(s) in months:

Shortest

Longest_

14.) During your tour(s) of duty, did you experience any combat-related activities?
(For example, patrols, under enemy fire, being surrounded by the enemy, kidnapped
or imprisoned, firing upon the enemy, hand to hand combat, pinned down, shot
down)
A) Yes B) No
15.) What are the principals type(s) of distressing experiences for which you are
seeking treatment? (Circle all the apply)
A) Witness death or execution
C) Witness major injuries (non-lethal)
E) Sexual assault
Thank you for your participation.
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B) IED blast or combat explosion
D) Physical assault
F) Other
Specify:

Appendix F:
Pittsburgh Sleep Quality Index (PSQI)
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Appendix G:
Center for Epidemiologic Studies Depression Scale (CES-D)
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Appendix H:
Institutional Review Board Approval
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